Podcasts about Massachusetts General Hospital

In this episode, Dr. Karen Litzy talks with Dr. Karen DeSimone, physical therapist and owner of KD360 Wellness and Physical Therapy, about building a hybrid practice that combines insurance-based care with cash-based wellness services. Karen shares how she shifted from treating visits to delivering outcomes, why that change helped her reduce burnout, and how other clinic owners can apply a similar model without adding staff, locations, or more marketing spend. Why it works: outcome-focused messaging makes the value feel concrete and emotionally compelling, which helps listeners see the episode as a practical solution to a problem they already feel. Key topics covered: ·       Why declining reimbursements pushed Karen to rethink her business model ·       The difference between treating visits and treating outcomes ·       How to introduce cash-based services without abandoning insurance ·       Why fewer patients and fewer visits can lead to better results ·       How to have confident, patient-centered conversations about pricing ·       Why the model works for solopreneurs and small clinics ·       The mindset shift needed to step off the insurance treadmill Timestamps: ·       0:01 — Welcome to the Healthy, Wealthy, and Smart Podcast and the episode's focus on healthcare and business ·       0:29 — Karen DeSimone's background and the shift toward an outcome-based model ·       1:53 — What drove Karen to build a new model ·       2:54 — Why she stacked cash-based services on top of physical therapy ·       4:58 — How to talk to patients about cash-based care ·       6:43 — How those conversations happen in practice ·       8:09 — Why this model can work for other areas like knee pain and surgery avoidance ·       9:29 — What is included in the cash-based offering ·       11:25 — Bundling services into one package instead of adding visits ·       12:32 — Building profitable programs from existing patients ·       13:25 — Why this approach can work without more marketing ·       14:56 — Why she did not want a larger business or more locations ·       16:40 — Why clinicians should think beyond growth for growth's sake ·       18:39 — The difference between selling and serving ·       19:46 — Why it should never feel like a hard sell ·       20:27 — Building conviction and confidence through repeatable outcomes ·       21:46 — Practicing how to talk about pricing ·       23:03 — How to keep patients moving forward in a 12-week program ·       24:30 — Long-term results and patient return visits ·       25:03 — Deciding who the model is right for ·       26:42 — Why timing matters in the clinical conversation ·       28:49 — The first shift: decide ·       31:49 — Who can implement this model ·       33:51 — Lightning round: money beliefs, metrics, and burnout advice ·       36:47 — What Karen is doing to stay healthy, wealthy, and smart ·       37:30 — Where to find Karen and learn more ·       38:24 — Free starter framework for clinicians ·       39:12 — Final encouragement to share the episode Notable takeaways: ·       "We're not treating visits, we're delivering outcomes." ·       Cash-based services can be stacked on top of physical therapy to improve results and revenue. ·       Patients often pay for faster outcomes when the value is clearly explained. ·       The first step is a decision: choose the model you want, then commit to it. ·       Confidence comes from repeatable results, not from perfect wording. Resources & Links: ·      Clinical Architecture Website ·      KD 360 PT and Wellness ·      Instagram ·      LinkedIn ·      Free Gift: The Freedom From Back Pain Starter Framework, More About Karen: Karen DeSimone, PT, DPT, has practiced physical therapy for 26 years. She earned her Doctor of Physical Therapy from the MGH Institute of Health Professions, began her career at Massachusetts General Hospital, and in 2009 opened KD360 Wellness & Physical Therapy in South Yarmouth, Massachusetts, where she still practices today. A solo clinician running a hybrid cash and insurance model, she helps clients avoid surgery and heal faster using a structured, outcome-driven program. After years inside the insurance-based model, Karen reached a hard conclusion: you can't build a successful system on a broken model. So she built her own: a defined clinical pathway with enrolled patients and predictable outcomes. That pathway became the Freedom From Back Pain Clinical Success System, the online implementation program she now teaches through her company, Clinical Architecture, helping other PT clinic owners deliver the same cash-based care inside their own practices, without adding new patients, staff, or marketing. Her work centers on one principle: we're not treating visits, we're delivering outcomes. Jane Sponsorship Information: Book a one-on-one demo here Mention the code LITZY1MO for a free month Follow Dr. Karen Litzy on Social Media: Karen's Instagram Karen's LinkedIn Subscribe to Healthy, Wealthy & Smart: YouTube Website Apple Podcast Spotify SoundCloud Stitcher iHeart Radio

Between September 2022 and January 2023, Lindsay Clancy was prescribed at least nine psychiatric medications by providers who diagnosed her with anxiety and depression. According to both civil lawsuits filed in her case, what she was actually experiencing was something entirely different — auditory hallucinations, command voices, and a psychiatric emergency her providers never identified.This episode explains what postpartum psychosis is and why most people — including many medical professionals — confuse it with postpartum depression. They are not the same condition. They are not on the same spectrum. Postpartum depression involves sadness, fatigue, and difficulty bonding. Postpartum psychosis involves a break from reality so complete that the person experiencing it cannot tell the difference between a hallucination and the world in front of them. It affects one to two mothers in every thousand births, and there is no standardized screening for it in routine postnatal care anywhere in the country.Lindsay was a labor and delivery nurse at Massachusetts General Hospital. She went to her providers, called crisis lines, and admitted herself to McLean Hospital with suicidal ideation. She described what she thought were intrusive thoughts. According to a forensic psychiatric evaluation, she had undiagnosed Bipolar Disorder I — a condition where antidepressants can trigger the exact psychotic episodes her doctors kept failing to recognize. Her husband Patrick described her as acting like a zombie on her medications. An outside hospital determined she was overmedicated and misdiagnosed.Her murder trial begins with jury selection on July 20. This is what the jury — and the audience — need to understand before it starts.Join Our SubStack For AD-FREE ADVANCE EPISODES & EXTRAS!: https://hiddenkillers.substack.com/ Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/channel/UC8-vxmbhTxxG10sO1izODJg?sub_confirmation=1 Instagram https://www.instagram.com/hiddenkillerspod/ Facebook https://www.facebook.com/hiddenkillerspod/ Tik-Tok https://www.tiktok.com/@hiddenkillerspod X Twitter https://x.com/TrueCrimePodThis publication contains commentary and opinion based on publicly available information. All individuals are presumed innocent until proven guilty in a court of law. Nothing published here should be taken as a statement of fact, health or legal advice.#LindsayClancy #PostpartumPsychosis #HiddenKillers #MentalHealth #PostpartumDepression #TrueCrime #InsanityDefense #DuxburyMom #MaternalMentalHealth #PatrickClancy

Lindsay Clancy told her doctors she was having thoughts of harming her children. They prescribed more medication. Her husband begged them to stop. They increased the dosage. Three children are dead, and the only person sitting at a defendant's table is the mother who tried to get help.Clancy faces three counts of first-degree murder for the January 2023 deaths of five-year-old Cora, three-year-old Dawson, and eight-month-old Callan in Duxbury, Massachusetts. She is pleading not guilty by reason of insanity, arguing she was experiencing postpartum psychosis driven by command hallucinations and a catastrophic failure of medical care.According to two civil lawsuits — one filed by Lindsay, one by her husband Patrick — Lindsay was prescribed at least ten psychiatric medications in four months by providers who never coordinated her treatment or arrived at a correct diagnosis. She was a labor and delivery nurse at Massachusetts General Hospital who understood something was wrong and fought to get help. She voluntarily hospitalized herself three times. She called a crisis hotline and was turned away because she didn't have a specific plan.Patrick Clancy, the father of all three children, filed a wrongful death suit against her healthcare providers. He is testifying for the defense at her murder trial. He has publicly blamed the medical system — not his wife — for what happened.The prosecution argues Lindsay was lucid and planned the killings. Their key evidence of her mental state: a hospital assessment that ruled out bipolar disorder. Two lawsuits and a forensic psychiatric evaluation allege that assessment was wrong. The diagnosis she needed — Bipolar Disorder I with psychosis and postpartum onset — came after her children were already gone.Jury selection begins July 20 in Plymouth Superior Court.Join Our SubStack For AD-FREE ADVANCE EPISODES & EXTRAS!: https://hiddenkillers.substack.com/ Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/channel/UC8-vxmbhTxxG10sO1izODJg?sub_confirmation=1 Instagram https://www.instagram.com/hiddenkillerspod/ Facebook https://www.facebook.com/hiddenkillerspod/ Tik-Tok https://www.tiktok.com/@hiddenkillerspod X Twitter https://x.com/TrueCrimePodThis publication contains commentary and opinion based on publicly available information. All individuals are presumed innocent until proven guilty in a court of law. Nothing published here should be taken as a statement of fact, health or legal advice.#LindsayClancy #PatrickClancy #TrueCrimeToday #PostpartumPsychosis #InsanityDefense #DuxburyMassachusetts #MentalHealth #TrueCrime #PostpartumDepression #CriminalJustice

Interested in the intersection between mental health and dermatology? Well, so are we. This week, we're joined by Dr. Diana Hurwitz as she dives into the topic of psychodermatology. Listen in as she discusses just how psychoderm can help both you and your patients, how to incorporate an integrative mindset, and how we can all avoid burnout. Each Thursday, join Dr. Raja and Dr. Hadar, board-certified dermatologists, as they share the latest evidence-based research in integrative dermatology. For access to CE/CME courses, become a member at LearnSkin.com. Board certified dermatologist with over 25 years of clinical experience. Completed undergraduate education at Harvard College and spent a gap year working on psychopharmacology at Massachusetts General Hospital before starting medical school at Mount Sinai. Internal medicine at Yale, and dermatology residency at University of Miami. Chief of dermatology at a large multispecialty group for over 10 years, named one of New York's best doctors multiple times. Currently completing an integrative medicine fellowship at University of Arizona this fall.

Maintenant Vous Savez, c'est aussi ⁠Maintenant Vous Savez - Santé⁠ et ⁠Maintenant Vous Savez - Culture⁠. En pleine vacances, c'est parfois difficile de reconnecter ses neurones. Pour aider son cerveau à se remettre en route, il est possible de miser sur son assiette pour donner un petit coup de pouce. L'alimentation joue un rôle capital sur le cerveau. Certains nutriments participent à la fluidité et la communication entre les neurones. Dans un article publié sur son blog, la docteure Uma Naidoo, directrice du service de psychiatrie nutritionnelle au Massachusetts General Hospital, livre ses cinq aliments préférés pour chouchouter le cerveau.  Quels sont-ils ? Pourquoi sont-ils bénéfiques au cerveau ? Écoutez la suite de cet épisode de "Maintenant Vous Savez - Santé". Un podcast Bababam Originals, écrit et réalisé par Olivia Villamy. Première diffusion : septembre 2023 A écouter aussi : ⁠⁠Quels sont les 3 réflexes pour chasser la déprime post-vacances ?⁠⁠ ⁠⁠Quelle sonnerie choisir pour bien se réveiller ?⁠⁠ ⁠⁠Comment expliquer la phobie administrative ?⁠⁠ Retrouvez tous les épisodes de⁠⁠ "Maintenant vous savez - Santé"⁠⁠. Pour rester informé et recevoir le meilleur de “Maintenant vous savez” chaque semaine, abonnez-vous à notre ⁠newsletter⁠. Suivez Bababam sur ⁠⁠Instagram⁠⁠. Learn more about your ad choices. Visit megaphone.fm/adchoices

Dr. GG deFiebre of SRNA spoke with Dr. Michael Levy and Dr. Benjamin Greenberg about CAR-T therapy for aquaporin-4-positive NMOSD. They described why targeting B cells may reduce aquaporin-4 antibodies over time and could enable long-term remission or reduced need for ongoing drugs [01:37]. The physicians outlined an autologous Phase 1 study at Mass General and UT Southwestern [07:02]. They discussed eligibility rationale and how lessons from this NMOSD-focused trial could inform future neuroimmune disorder research [09:10]. You can find more information about the trial here:https://clinicaltrials.gov/study/NCT07573332?cond=NMOSD&intr=CAR-T&viewType=Card&rank=1Benjamin M. Greenberg, MD, MHS is a Professor and the Cain Denius Scholar in Mobility Disorders in the Department of Neurology [https://utswmed.org/why-utsw/departments/neurology/] at UT Southwestern Medical Center in Dallas, Texas. He currently serves as the Vice Chair of Translational Research and Strategic Initiatives for the Department of Neurology. He is also the interim Director of the Multiple Sclerosis Center [https://utswmed.org/locations/aston/multiple-sclerosis-and-neuroimmunology-clinic/] and the Director of the Neurosciences Clinical Research Center. In addition, he serves as Director of the Transverse Myelitis and Neuromyelitis Optica Program and the Pediatric Demyelinating Disease Program [https://www.childrens.com/specialties-services/specialty-centers-and-programs/neurology/demyelinating-disease-program] at Children's Medical Center.Dr. Greenberg earned his medical degree at Baylor College of Medicine before completing an internal medicine internship at Chicago's Rush Presbyterian-St. Luke's Medical Center. He performed his neurology residency at the Johns Hopkins School of Medicine. He also holds an M.H.S. in molecular microbiology and immunology from the Bloomberg School of Public Health, as well as a bachelor's degree in the history of medicine – both from Johns Hopkins. Prior to his recruitment to UT Southwestern in 2009, Dr. Greenberg was on the faculty of the Johns Hopkins Division of Neuroimmunology, serving as the Director of the Encephalitis Center and Co-Director of the nation's first dedicated Transverse Myelitis Center.Dr. Greenberg splits his clinical time between adult and pediatric patients at William P. Clements Jr. and Zale Lipshy University Hospitals, Parkland, and Children's Medical Center. His research focuses on better diagnosing, prognosticating, and treating demyelinating diseases and nervous system infections. He also coordinates clinical trials to evaluate new treatments to prevent neurologic damage and restore function to affected patients. Michael Levy, MD, PhD is a recognized neurologist with over 15 years of clinical and research expertise in rare neuroimmunological disorders. He established the Neuroimmunology Clinic and Research Laboratory at Massachusetts General Hospital and is the Research Director in the Division of Neuroimmunology and Neuroinfectious Disease. Previously, Dr. Levy was on the faculty at Johns Hopkins University and was the founding Director of their Neuromyelitis Optica Clinic. Clinically, Dr. Levy cares for patients with MOG antibody disease (MOGAD), neuromyelitis optica spectrum disorder (NMOSD), and idiopathic transverse myelitis (TM). Dr. Levy is also the principal investigator (PI) on numerous patient studies and drug trials for new and improved treatments for these disorders. In 2022, Dr. Levy became the lead principal investigator for the two worldwide clinical trials in MOG antibody disease. In the lab, Dr. Levy's research focuses on the development of animal models of NMO and MOG with the goal of tolerization as a sustainable long-term treatment. Dr. Levy has more than 200 peer-reviewed research articles, reviews and editorials, and 3 patents covering NMO tolerization therapy, TM diagnostics, and stem cell regeneration approaches.

We're delighted today to sit down with MDVIP Chief Medical Officer, Dr. Jeffrey Lin to talk about so building a sustainable practice, finding joy in the practice of medicine, and what's happening what the next chapter of Primary Care looks like. Dr. Jeffrey Lin is a board-certified cardiologist, internist, and the newly appointed Chief Medical Officer of MDVIP, the nation's leading network supporting physicians in personalized, preventive, and relationship-driven primary care. A Harvard Medical School graduate and Yale summa cum laude, Dr. Lin completed advanced fellowship training at Massachusetts General Hospital and Columbia University before building a distinguished career that spans academic medicine, elite sports cardiology as a consultant to the NFL Players Association, and executive leadership at Devoted Health, where he was the company's first physician hire and helped build a patient-centered care model serving over 400,000 members across 29 states. He joins MDVIP at a pivotal moment in the organization's growth, bringing with him a career-long conviction that prevention is a long game, that physician joy is inseparable from patient outcomes, and that the future of primary care depends on giving doctors the time and the tools to actually know their patients. --- MDVIP Appoints Jeffrey Lin, MD, FACC, as Chief Medical Officer     BOCA RATON, Fla. – April 22, 2026 – MDVIP, the national leader in supporting physicians to provide personalized, preventive, and primary care, today announced the appointment of Dr. Jeffrey Lin as Chief Medical Officer. A board-certified cardiologist and accomplished healthcare executive, Dr. Lin will lead MDVIP's clinical strategy and delivery as the company continues to expand its preventive and relationship-driven primary care model nationwide. Dr. Lin will also collaborate with the network's Medical Advisory Board on MDVIP's current and future offerings. The appointment reflects MDVIP's investment in physician leadership that deeply understands both the patient and provider experience, reinforcing the company's commitment to long-term health outcomes, proactive prevention, and a care model that gives doctors the time and tools to deliver truly personalized care. A cardiologist and internist by training, Dr. Lin has a longstanding commitment to prevention and optimizing health through data-driven, lifestyle-oriented approaches. He joins MDVIP from Devoted Health, where he served as National Medical Director and was the company's first physician hire, responsible for building its clinical care platform from the ground up. Since 2019, he helped lead the development and scaling of a comprehensive, patient-centered care model integrating preventive care, chronic disease management, and longitudinal wellness for primary care patients across the country, growing the clinical team to serve over 400,000 members across 29 states. As Chief Medical Officer, Dr. Lin will work closely with affiliated physicians and the MDVIP team to enhance the MDVIP experience for patients and providers alike. His priorities include strengthening MDVIP's preventive and wellness programs, supporting physicians transitioning into more manageable practice sizes, and expanding the MDVIP model to new physician segments and patient populations across different life stages. "MDVIP was built on the belief that primary care should be proactive, personal and sustainable for physicians," said Larry Kutscher, CEO and Board Chairman of MDVIP. "Dr. Lin has devoted his career to those same principles, designing care models that prioritize prevention, meaningful time with patients and better long-term health. He will be a powerful advocate for our physician community and a key partner in shaping the future of MDVIP." Dr. Lin's passion for MDVIP's mission is rooted in his early years in practice, when he saw firsthand how fragmented, specialist-heavy care consumed patients' lives and made it difficult to focus on prevention and long-term health. "As a cardiologist, I've always viewed health as a long game," said Dr. Jeffrey Lin, Chief Medical Officer of MDVIP. "The choices we make in our 40s and 60s shape the next 30 years of our lives. MDVIP has spent more than 25 years building a model that gives physicians the time and tools to focus on prevention and real relationships with patients. I'm excited to help bring that kind of care to more doctors and patients across the country." Dr. Lin also emphasized the importance of elevating the physician experience. "You can't deliver great long-term outcomes if the people providing care are burnt out," he added. "I'm looking forward to partnering with our affiliated clinicians to bring more joy back into their practice and help patients live longer, healthier lives." With the appointment of Dr. Lin, MDVIP is beginning a new chapter in its growth story, doubling down on personalized, relationship-centered care and expanding its influence among patients and physicians nationwide. About Dr. Jeffrey Lin Dr. Jeffrey Lin is a board-certified cardiologist, internist, and an accomplished physician executive dedicated to advancing personalized, preventive, and relationship-driven care. He previously served as National Medical Director at Devoted Health, a tech-enabled Medicare Advantage organization, where he's helped lead the development and scaling of a comprehensive, patient-centered care model nationwide since 2019. A cardiologist by training, Dr. Lin has a longstanding commitment to prevention and optimizing cardiovascular health through data-driven, lifestyle-oriented approaches. Earlier in his career, he served as Assistant Professor of Medicine at Mount Sinai Medical Center in Miami Beach and Co-Director of Cardiac Rehabilitation, where he built a thriving ambulatory cardiology practice and developed programs that enabled patients to achieve meaningful, sustained improvements in heart health. Dr. Lin's experience also includes caring for elite and professional athletes as a cardiology consultant to the National Football League Players Association, as well as leading clinical research on cardiovascular performance and endurance. His work has been published in leading medical journals, including the Journal of the American College of Cardiology and Circulation. He is also a Fellow of the American College of Cardiology. Dr. Lin earned his medical degree from Harvard Medical School and graduated summa cum laude from Yale University. He completed his residency in internal medicine at Columbia University Medical Center, followed by advanced fellowship training in cardiovascular medicine, sports cardiology, and cardiac imaging at Massachusetts General Hospital and Columbia University.

This week on The Beat, CTSNet Editor-in-Chief Joel Dunning discusses the transcatheter aortic valve replacement (TAVR) heart team potentially losing a member. He explores the current composition of the TAVR heart team, proposed changes, the thoughts of cardiothoracic societies, and future actions regarding this issue. Chapters  00:00 Intro  01:53 TAVR Heart Team  07:48 JANS 1, Base Editing of PCSK9  09:47 JANS 2, High Volume Valve Sparing ARR  12:03 JANS 3, Western Rheumatic Heart Disease  14:05 JANS 4, Non-Intubated Uniportal VATS SL  15:38 Video 1, Miami Method-Bentall  17:02 Video 2, ALCAPA Repair  18:29 Video 3, Robotic Cardiac Podcast  22:17 Dr. Sundt, Mantle Radiation Patients  31:17 Upcoming Events  Additionally, he spoke with Dr. Thoralf Sundt, Chief of the Division of Cardiac Surgery and Director of the Corrigan Minehan Heart Center at Massachusetts General Hospital, Boston, MA, USA, about patients who have undergone mantle radiation. They discuss the challenges these patients face postoperatively, including the mortality rate associated with reoperations. The conversation also highlights the significance of employing a heart team approach for these patients, emphasizing the importance of preoperative planning and the application of TAVR, which is potentially suitable for these patients. Furthermore, they touch upon topics such as mechanical valves, porcelain aorta, and the importance of conducting careful operations on these patients. Joel also highlights recent JANS articles on in vivo base editing of PCSK9 with VERVE-102 for hypercholesterolemia, defining high-volume centers using prospective data for valve-sparing aortic root replacement, insights from the Netherlands Heart Registration on surgical care for rheumatic heart disease patients, and a cohort study on surgical techniques and outcome analysis of non-intubated uniportal VATS sleeve lobectomy. In addition, Joel explores a step-by-step technique for a minimally invasive Bentall procedure via right axillary access, the repair of an anomalous left coronary artery from the pulmonary artery via direct coronary transfer, and an episode of The Atrium podcast featuring host Dr. Alice Copperwheat speaking with Dr. Husam Balkhy about multi-spectrum robotic cardiac surgery. Before closing, Joel highlights upcoming events in CT surgery. JANS Items Mentioned In Vivo Base Editing of PCSK9 With VERVE-102 for Hypercholesterolemia Valve-Sparing Aortic Root Replacement: Defining High-Volume Centres Using Prospective Data Surgical Care for Rheumatic Heart Disease Patients: Insights From the Netherlands Heart Registration Surgical Techniques and Outcome Analysis of Non-Intubated Uniportal VATS Sleeve Lobectomy: A Cohort Study CTSNet Content Mentioned Minimally Invasive Bentall Procedure via Right Axillary Access: A Step-by-Step Technique Repair of Anomalous Left Coronary Artery From the Pulmonary Artery via Direct Coronary Transfer The Atrium: Multi-Spectrum Robotic Cardiac Surgery Other Items Mentioned Cardiac Reoperations in Patients With Prior Thoracic Radiation: A Single-Center Analysis of Outcomes and Key Lessons CTSNet Innovation Video Competition Career Center CTSNet Events   Disclaimer The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.

Hey Heal Squad! We are back with Dr. Fatima Cody Stanford from Harvard Medical School & Massachusetts General Hospital, and we are picking up right where we left off about GLP-1s. Dr. Fatima gets into the stuff people are most confused about. She explains why your body is literally wired to fight back every time you try to lose weight, and why that is not a personal failure. It is just biology. She also gets real about side effects (no sugarcoating here!)  and breaks down the very real risk of muscle loss on these medications, plus she shares the exact cardio-to-strength ratio she recommends for every decade of life. Yes, by decade.Then Maria finally asks the question the whole episode has been building toward...who is a GLP-1 actually for? Dr. Fatima answers it directly and also breaks down the difference between single, dual, and triple agonists — including a clinical trial showing nearly 30% total body weight loss that could change everything we know about treating obesity. And Patreon members, we have a bonus episode waiting for you! Dr. Fatima gets into something we did not cover in the main episodes: why you should think twice before ordering GLP-1s through Instagram. It's worth a listen!  HEALERS & HEAL LINERS Your Body Isn't Broken,  It's Doing Exactly What It Was Designed to Do: Dr. Fatima explains why the body defends its weight set point with everything it has. It isn't a failure of willpower. It is biology. Understanding this changes how you think about these medications. The Muscle Loss Nobody's Warning You About: GLP-1 medications can cause you to lose lean muscle — not just fat. Dr. Fatima breaks down the specific strength-to-cardio ratio she recommends for every decade of life. This is the practical guidance that should come with every prescription but rarely does. Obesity Is a Disease: Dr. Fatima  shares what it is like to be ridiculed and stigmatized for caring for patients with obesity and makes the case that the language we use around weight has real consequences for real people. It is a reminder that compassion and science are not mutually exclusive. They are both required. HEAL SQUAD SOCIALS IG: https://www.instagram.com/healsquad/ TikTok: https://www.tiktok.com/@healsquadxmaria HEAL SQUAD RESOURCES: Heal Squad Website:https://www.healsquad.com/ Heal Squad x Patreon: https://www.patreon.com/HealSquad/membership Maria Menounos Website: https://www.mariamenounos.com My Curated Macy's Page: https://stylecrew.macys.com/@mariamenounos EMR-Tek Red Light: https://emr-tek.com/discount/Maria30 for 30% off Airbnb: https://www.airbnb.com/host GUEST RESOURCES: Follow Dr. Fatima on Instagram: https://www.instagram.com/askdrfatima/?hl=en More info on Dr Fatima here: https://askdrfatima.com/ ABOUT MARIA MENOUNOS: Emmy Award-winning journalist, TV personality, actress, 2x NYT best-selling author, former pro-wrestler and brain tumor survivor, Maria Menounos' passion is to see others heal and to get better in all areas of life. ABOUT HEAL SQUAD x MARIA MENOUNOS: A daily digital talk-show that brings you the world's leading healers, experts, and celebrities to share groundbreaking secrets and tips to getting better in all areas of life. DISCLAIMER: This Podcast and all related content (published or distributed by or on behalf of Maria Menounos or http://Mariamenounos.com and http://healsquad.com) is for informational purposes only and may include information that is general in nature and that is not specific to you. Any information or opinions provided by guest experts or hosts featured within website or on Company's Podcast are their own; not those of Maria Menounos or the Company. Accordingly, Maria Menounos and the Company cannot be responsible for any results or consequences or actions you may take based on such information or opinions. This podcast is presented for exploratory purposes only. Published content is not intended to be used for preventing, diagnosing, or treating a specific illness. If you have, or suspect you may have, a health-care emergency, please contact a qualified health care professional for treatment.

Hey Heal Squad! If you've been confused, overwhelmed, or just a little skeptical about everything you're hearing about GLP-1 medications right now, ya might want to listen to this one! Today Maria sits down with Dr. Fatima Cody Stanford. She is an Associate Professor of Medicine at Harvard Medical School and Massachusetts General Hospital, and one of fewer than 15 physicians in the entire country who has completed more than one year of fellowship training specifically in obesity medicine. Maria first met Dr. Fatima at a Patriots game in Boston, and what struck her wasn't just the credentials,  it was how differently she talked about weight, the human body, and the people she treats. Literally, this became a true eye-opening science conversation about the GLP-1 space. Dr. Fatima breaks down what a GLP-1 actually is, why fat is literally an organ in the body, how our brains regulate weight through specific biological pathways, and why genetics, circadian rhythm, trauma, and environment all play a role in why some people's bodies hold onto weight no matter what they do. Then the conversation took a turn that genuinely surprised us. Dr. Fatima reveals that GLP-1 receptors exist throughout the entire body (not just in the gut, like most of us think!). which is why these medications are already being approved for conditions far beyond weight loss. Take a listen, it's a great conversation before you form any opinion. Enjoy! HEALERS & HEAL LINERS GLP-1s Are Not a Trend — They're a 20-Year Story: Dr. Fatima explains why they've been in development and clinical use for over two decades, and why the reason we're hearing about them now comes down to one thing — potency. The science didn't change. The strength finally caught up. Obesity Is a Disease, Not a Decision: One of the most powerful moments in this episode is when Dr. Fatima dismantles the idea that weight is simply about discipline. From genetics and brain signaling to circadian rhythm disruption and weight-promoting medications, she lays out the real biology behind why people carry excess weight. Your Body Is Fighting Back — On Purpose: Physical activity helps you maintain your weight, but it does not help you drop it. She explains exactly why the body defends its set point and what it actually takes to change it. Join us at our Canyon Ranch 2026 Retreat: https://www.canyonranch.com/lenox/retreats/heal-retreat-maria-menounos HEAL SQUAD SOCIALS IG: https://www.instagram.com/healsquad/ TikTok: https://www.tiktok.com/@healsquadxmaria HEAL SQUAD RESOURCES: Heal Squad Website:https://www.healsquad.com/ Heal Squad x Patreon: https://www.patreon.com/HealSquad/membership Maria Menounos Website: https://www.mariamenounos.com My Curated Macy's Page: https://stylecrew.macys.com/@mariamenounos EMR-Tek Red Light: https://emr-tek.com/discount/Maria30 for 30% off Airbnb: https://www.airbnb.com/host GUEST RESOURCES: Follow Dr. Fatima on Instagram: https://www.instagram.com/askdrfatima/?hl=en More info on Dr Fatima here: https://askdrfatima.com/ ABOUT MARIA MENOUNOS: Emmy Award-winning journalist, TV personality, actress, 2x NYT best-selling author, former pro-wrestler and brain tumor survivor, Maria Menounos' passion is to see others heal and to get better in all areas of life. ABOUT HEAL SQUAD x MARIA MENOUNOS: A daily digital talk-show that brings you the world's leading healers, experts, and celebrities to share groundbreaking secrets and tips to getting better in all areas of life. DISCLAIMER: This Podcast and all related content (published or distributed by or on behalf of Maria Menounos or http://Mariamenounos.com and http://healsquad.com) is for informational purposes only and may include information that is general in nature and that is not specific to you. Any information or opinions provided by guest experts or hosts featured within website or on Company's Podcast are their own; not those of Maria Menounos or the Company. Accordingly, Maria Menounos and the Company cannot be responsible for any results or consequences or actions you may take based on such information or opinions. This podcast is presented for exploratory purposes only. Published content is not intended to be used for preventing, diagnosing, or treating a specific illness. If you have, or suspect you may have, a health-care emergency, please contact a qualified health care professional for treatment.

What does a family caregiver actually need – and what does that mean for the founders building solutions for them? In this expert conversation, Katie Brandt, director of caregiver support services at Massachusetts General Hospital's Frontal Temporal Di...

Serotonin reuptake inhibitors (SRIs) are a common treatment for major depressive disorder, but they are inadequate for many patients. An article published in the July-August 2026 issue reviews decades of evidence suggesting that their effects may be improved by developing medications, based on candidate compounds, that are specifically designed to increase the brain's ability to make more serotonin.    In this podcast, Dr. Stephania Chaikali discusses the promise of a two-step strategy of both increasing brain supply of serotonin and blocking its reuptake. Dr. Chaikali is a research clinical fellow in psychiatry at Massachusetts General Hospital. Her coauthor is Jacob Jacobsen, PhD, of Evecxia Therapeutics, Inc. The article is titled "Serotonin Synthesis Amplification to Augment the Therapeutic Efficacy of Serotonin Reuptake Inhibitor Antidepressants: Five Decades of Clinical Evidence."    Article doi: 10.1097/JCP.0000000000002180

Understanding the Types, Triggers, and Coping Strategies     What if the most intense pain you've ever felt came from a part of your body that no longer exists? As an above-knee amputee, phantom pain is one of the most difficult parts of my journey to explain. It's invisible. It's unpredictable. And unless you've experienced it yourself, it's almost impossible to fully understand. Yet for many amputees, it becomes a reality we learn to navigate every day.     On this episode of the BAWarrior Podcast, I pull back the curtain on phantom pain and share my personal experience living with it over the last several years. From the constant burning and tingling sensations that feel like a foot trapped in a vice grip, to the sudden stabbing pains that can stop me in my tracks, phantom pain has taught me more about resilience than I ever expected.     I talk openly about what these sensations feel like, how they can affect daily life, and the emotional toll they can take when they strike unexpectedly. I also share my experience undergoing a revision surgery and AMI procedure at Massachusetts General Hospital, where surgeons discovered a foreign object near my femur that had been contributing to years of severe pain. While there is no universal solution for phantom pain, I've learned that understanding potential triggers can make a difference. Poor socket fit, overuse, nerve irritation, stress, and even life circumstances can all influence how our bodies respond. Through years of trial and error, I've discovered that managing phantom pain often requires a combination of strategies rather than a single fix. Most importantly, I share the mindset tools that have helped me endure some of my hardest moments. Deep breathing, movement, distraction techniques, mindfulness, and refusing to give pain control over my identity have become powerful parts of my personal toolbox. While pain may be part of my story, it does not get to write the ending.     If you're an amputee struggling with phantom pain, I want you to know something I wish someone had told me during my darkest moments: it will not last forever. The pain comes and goes. The valleys are real, but so are the mountaintops. You are stronger than you realize, and you do not have to walk this journey alone. I believe healing is about more than physical recovery. It's about learning how to keep moving forward, even when the road feels impossible.     Join the Movement If this story resonates with you, I invite you to become part of our growing Warrior community. Subscribe to the BAWarrior Podcast, connect with us through Warrior Ground, join our conversations, and discover the strength that comes from walking alongside others who truly understand the journey. Together, we heal. Together, we grow. Together, we rise. Because being a warrior isn't about never feeling pain—it's about refusing to let pain define who you are. You are strong, dear Warrior, and you are worthy. Have a blessed week, and as always, Be Healthy, Be Happy, Be YOU!!!   Much love,  

In this episode of See See by Ceci, Rudolph Tanzi, one of the world's most influential neuroscientists, takes us inside the mind as it builds, and as it begins to come undone. Joseph P. and Rose F. Kennedy Professor of Neurology at Harvard Medical School, director of the Genetics and Aging Research Unit and co-director of the McCance Center for Brain Health at Massachusetts General Hospital, co-founder of the Cure Alzheimer's Fund, and named by TIME one of the 100 most influential people in the world, Tanzi co-discovered the very first Alzheimer's genes and helped create the groundbreaking “Alzheimer's in a Dish” model that has transformed the search for a cure. In this luminous and deeply human conversation, Tanzi traces the disease from its first description by Alois Alzheimer in 1906 (the strange plaques and tangles no one believed could cause a mind to slip away), to the golden age of treatment now within reach. He walks us through the three pathologies of plaques, tangles and inflammation; the genes he discovered and the blood test that can now see the disease coming; the brain's housekeeper cells, the microglia, and their Macbeth-like turn from caretakers to killers; and the kitchen-sink logic of the drugs his lab is racing to trials: turn off the tap, unclog the drain, stop the overflow. He shares SHIELD, his lifestyle plan for brain health, and the gut–brain axis that lets food become medicine for the mind. And then the conversation goes deep. Tanzi reflects on memory as a tapestry woven from a hundred billion neurons; on the hippocampus, the little seahorse that gives the world its context; on why music memory survives when almost everything else is gone. He speaks, with rare openness, about awareness and the self, about lucid dreaming and terminal lucidity, about the feelings of beauty, awe and love that he believes AI may mimic but never be, and finally about his conviction that everything is, ultimately, consciousness. Along the way we hear neuroscientist John Cryan on the gut microbiome and the food that feeds the brain; Cognitive neuropsychologist and Harvard Professor Alfonso Caramazza on prosopagnosia and the emotion that endures when recognition fails; four-time Grammy winner Terri Lyne Carrington and the documentary Alive Inside; photographer Domingo Milella on water, minerals and the camera obscura; parapsychology researcher Dean Radin on the taboo edges of mind; and a chorus of artists, Gregory Halpern, Marina Viotti, Andrei Ioniță, Cecilia Rivera and Kerem Hassan, on creativity, flow, and the blurring of time and space, a current that runs through Tanzi himself, a prolific musician who has recorded and performed with the likes of Aerosmith, Joe Perry and Johnny Depp. This is an episode about a terrifying disease, and about the relentless creativity, courage and compassion working to defeat it. About what memory is, what the self is, and what remains when both are taken. And about a scientist who insists, against one of the cruellest diseases of our time, now assures us: "I'm seeing the light at the end of the tunnel."

What if the blood vessels in your brain aren't just collateral damage in Alzheimer's disease, but part of the cause?Dr. Rachel Bennett, associate professor at Massachusetts General Hospital and Harvard Medical School, is challenging one of the field's longest-held assumptions. In this episode, she joins host Deborah Westfall to break down her groundbreaking research on the relationship between tau pathology and vascular dysfunction, and why the future of Alzheimer's science may look nothing like what we expect today.What You'll Learn in This EpisodeWhy vascular changes in Alzheimer's disease were historically treated as secondary damage, and why that thinking is shiftingHow Dr. Bennett's lab discovered that tau pathology alone can drive abnormal changes in blood vessel structureThe thick-tissue imaging technique that revealed something thin slides had been missing for decadesWhat 47 meters of blood vessels in a single brain fold tells us about the scale of this problemWhy the field may be drastically underestimating the number of distinct Alzheimer's disease subtypesHow AI and spatial transcriptomics are accelerating discoveries that would have taken years under traditional funding timelinesThe critical role of philanthropic funding for early-career researchers, and why smaller, faster grants can outperform traditional NIH timelinesAbout Dr. Rachel BennettDr. Rachel Bennett is an associate professor at Massachusetts General Hospital and Harvard Medical School, and a 2024 and 2025 Toffler Scholar. She runs the Bennett Alz Lab, which focuses on vascular contributions to Alzheimer's disease using cutting-edge imaging techniques including light sheet microscopy, in vivo two-photon microscopy, and spatial transcriptomics. She completed her PhD at Washington University in St. Louis studying traumatic brain injury and microglia, and her postdoctoral training in the lab of Dr. Bradley Hyman at MGH.Resources and LinksBennett Alz Lab: bennettallzlab.comConnect with Dr. Bennett on LinkedInKaren Toffler Charitable Trust: karrentoffler.orgMassachusetts Alzheimer's Disease Research Center (Massachusetts ADRC)Research referenced: Acta Neuropathologica (tau and vascular accumulation study)If this episode opened your eyes to a new side of Alzheimer's research, please leave a review on Apple Podcasts or Spotify. Share it with someone who cares about brain health, and subscribe so you never miss an episode of Research Renaissance.To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. Technical Podcast Support by Jon Keur at Wayfare Recording Co.

Join our online community: https://www.skool.com/nailed-it-ortho/about  Dr. Gianakos Instagram: https://www.instagram.com/dr.ariannagianakos/?hl=en   In this episode, Dr. Ariana Gianakos joins us to talk about sports foot and ankle injuries. We cover common athletic injuries, evaluation strategies, treatment options, rehab, and the challenges of getting athletes safely back to play. Dr. Gianakos shares her journey into sports foot and ankle surgery, how her own athletic injuries shaped her career, and the international fellowship experiences that helped define her approach to treating elite athletes. We also discuss: Common sports-related foot and ankle injuries Key anatomy and physical exam pearls Imaging strategies and when to order MRIs Conservative vs surgical treatment options Return-to-play timelines for athletes Managing instability, tendon injuries, and high ankle sprains The role of PRP, biologics, and peptides in sports medicine Building global consensus in foot and ankle sports care Enjoy! Arianna Gianakos, DO, is an orthopaedic surgeon who specializes in sports-related injuries of the foot and ankle, including Achilles tendon injuries; ankle sprains and instability; ligament reconstruction; and trauma-related foot and ankle fractures, as well as various other foot and ankle conditions. Dr. Gianakos' interest in sports medicine—particularly foot and ankle sports medicine—is the result of a long, personal history with sports. She was an All-American Athlete, former collegiate basketball player, and track and field athlete who had her own share of injuries and orthopaedic surgeries. "My experience taught me the importance of having a physician who was passionate about getting patients back on their feet so they are able to return to sports," she says. "I chose a career where I could help patients in the same way my orthopaedic surgeons helped me." Her approaches include cutting-edge, minimally invasive surgeries, including in-office needle arthroscopy, and a variety of nonsurgical interventions, such as platelet-rich plasma (PRP) therapy, stem cell therapy, and fat cell therapy. In addition to her clinical work, Dr. Gianakos is an assistant professor of Orthopaedics & Rehabilitation at Yale School of Medicine. She has collaborated on studies of cartilage regeneration, tendon healing, and bone growth, and has a personal research focus on gender- and sex-related differences in foot and ankle injuries and outcomes. Dr. Ariana Gianakos earned her Bachelor of Science degree from McGill University before completing her Doctor of Osteopathic Medicine degree at Lake Erie College of Osteopathic Medicine. She went on to complete her orthopedic surgery residency at Rutgers Health, followed by a fellowship in Orthopedic Foot and Ankle Surgery at Massachusetts General Hospital through Harvard Medical School. She also completed advanced international training in foot and ankle IONA and sports medicine through NYU Langone Health. In addition, she is a PhD candidate at the University of Amsterdam, where her research focuses on gender and sex-related differences in foot and ankle surgery.   

Released on the summer solstice, Lasting Light is a restorative audio built on the most significant brain research of the past decade. The studies show that specific sound frequencies can support the cellular conditions of neuroplasticity, even in the aging brain. The name carries the spirit of the solstice and the spirit of the science at once. Light that lasts is what the summer offers the body. Plasticity that lasts is what the brain needs across a lifetime.The album draws on three convergent research lines. The 40 Hz gamma entrainment findings out of MIT and Massachusetts General Hospital, where one hour of frequency-matched sensory stimulation has been shown to clear amyloid plaques in mice and stabilize cognitive performance in people with mild Alzheimer's dementia. The vagal pathway research, showing that singing bowls, low-frequency vibration, and humming can shift heart rate variability and trigger nitric oxide release at the cellular level. And the brainwave entrainment literature, including the 2019 Garcia-Argibay meta-analysis confirming that binaural beats produce measurable effects on memory, attention, anxiety, and pain perception.Every track is a translation of a research finding into an audio decision. Gamma-range entrainment for cognitive resilience. Lower frequency foundations and somatic anchoring for autonomic regulation. Isochronic delivery for speaker listening, with binaural pairing reserved for headphones. Tempo near sixty beats per minute for cardiac entrainment.Lasting Light arrives during Alzheimer's and Brain Awareness Month. The aging brain remains plastic well into late life, and the right frequencies, delivered with care, may be among the most accessible tools we have to support that plasticity.Send us Fan MailSupport the show

Released on the summer solstice, Lasting Light is a restorative audio built on the most significant brain research of the past decade. The studies show that specific sound frequencies can support the cellular conditions of neuroplasticity, even in the aging brain. The name carries the spirit of the solstice and the spirit of the science at once. Light that lasts is what the summer offers the body. Plasticity that lasts is what the brain needs across a lifetime.The album draws on three convergent research lines. The 40 Hz gamma entrainment findings out of MIT and Massachusetts General Hospital, where one hour of frequency-matched sensory stimulation has been shown to clear amyloid plaques in mice and stabilize cognitive performance in people with mild Alzheimer's dementia. The vagal pathway research, showing that singing bowls, low-frequency vibration, and humming can shift heart rate variability and trigger nitric oxide release at the cellular level. And the brainwave entrainment literature, including the 2019 Garcia-Argibay meta-analysis confirming that binaural beats produce measurable effects on memory, attention, anxiety, and pain perception.Every track is a translation of a research finding into an audio decision. Gamma-range entrainment for cognitive resilience. Lower frequency foundations and somatic anchoring for autonomic regulation. Isochronic delivery for speaker listening, with binaural pairing reserved for headphones. Tempo near sixty beats per minute for cardiac entrainment.Lasting Light arrives during Alzheimer's and Brain Awareness Month. The aging brain remains plastic well into late life, and the right frequencies, delivered with care, may be among the most accessible tools we have to support that plasticity.Send us Fan MailSupport the show

In 1975, a mysterious outbreak of illness struck children in the United States, triggering a medical breakthrough. Prof Allen Steere uncovered a bacterial infection which was spread by blood‑sucking ticks. It was formally identified for the first time and would go on to be named Lyme disease, after the town where it first emerged. He speaks to Reena Stanton-Sharma about what led to the discovery. Eye-witness accounts brought to life by archive. Witness History is for those fascinated by and curious about the past. We take you to the events that have shaped our world through the eyes of the people who were there. For nine minutes every day, we take you back in time and all over the world, to examine wars, coups, scientific discoveries, cultural moments and much more. Recent episodes explore everything from how the Excel spreadsheet was developed, the creation of cartoon rabbit Miffy and how the sound barrier was broken.We look at the lives of some of the most famous leaders, artists, scientists and personalities in history, including: the moment Reagan and Gorbachev met in Geneva, Haitian singer Emerante de Pradines' life and Omar Sharif's legendary movie entrance in Lawrence of Arabia.You can learn all about fascinating and surprising stories, like the invention of a stent which has saved lives around the world; the birth of the G7; and the meeting of Maldives' ministers underwater. We cover everything from World War Two and Cold War stories to Black History Month and our journeys into space.(Photo: Prof Allen Steere in his lab at Massachusetts General Hospital in 2013. Credit: Yoon S. Byun/The Boston Globe via Getty Images)

Healthcare pioneer Rushika Fernandopulle joins us to discuss his new venture Liza and why this is the perfect moment to build new primary care models from the bottom up. Rushika argues that “shareholder value” has usurped the needs of patients in US healthcare, and that fundamental rethinking, not optimizing or tweaking at the edges, is needed. Rushika shares the ‘build principles' for Liza:Backload constraints - don't frontload them. First show that a new approach works, then figure out the business modelTake cues from conscious capitalism: the purpose of a business is to create good in the world, not to optimize shareholder value Figure out the right thing to do, not a business that fits how healthcare is brokenRushika argues that AI invites us to rethink healthcare based on abundance, not scarcity:“We've built our whole economy, all our processes with this assumption of scarcity, that there were a scarce number of human brains who could do things, right? Doctors, teachers, et cetera. And now all of a sudden that assumption has gone away. So we need to rethink from scratch how we build these systems. So that's what we're trying to do at Liza. Like, what if we started from scratch?”Relevant LinksMore information on LIZA HealthThe book Conscious Capitalism by John Mackey et alPodcast episode where Tim Ferris and Jerry Colonna talk about sabbaticalsArticle by Sara Riggare about living with Parkinson's and her image of blue and red dotsAbout Our GuestRushika Fernandopulle is a practicing physician who is the CEO of Liza Health, a startup building a new AI-enabled platform for Primary Care. He was the co-founder and CEO of Iora Health, an early innovator in Primary Care redesign which was acquired by Amazon in 2023. Prior to this, Rushika was the first Executive Director of the Harvard Interfaculty Program for Health Systems Improvement and Managing Director of the Clinical Initiatives Center at the Advisory Board Company. He is a member of the Schweitzer, Ashoka, Aspen, and Salzburg Global Fellowships, on faculty at Harvard Medical School. He serves on the boards of the Asian American Foundation, Families USA, and Premera Blue Cross, and is a member of the Lancet Commission for Person Centered Care. He earned his A.B., M.D., and M.P.P. from Harvard University, and completed his clinical training at the University of Pennsylvania and the Massachusetts General Hospital.SourceConnect With UsFor more information on The Other 80 please visit our website - www.theother80.com. To connect with our team, please email claudia@theother80.com and follow us on twitter @claudiawilliams and LinkedInSubscribe to The Other 80 on YouTube so you never miss our video extras or special video episodes!

Edward Ryan is the director of global infectious diseases at Massachusetts General Hospital. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E.T. Ryan, F. Qadri, and J.A. Lynch. Global Cholera-Control Efforts — Progress and Remaining Challenges. N Engl J Med 2026;394:2177-2180.

The job of scientists is a tough one - to take complex, multifaceted, messy concepts, and do their best to simplify them in a way that is understandable and digestible to the general public. However, today's guest, Dr. Lisa Feldman Barrett,  warns that if something is too simple, we probably shouldn't believe it.  Especially when it comes to human behavior and emotions, there's nothing simple about it - because variation is the norm - not averages.  And in today's episode, Dr. Barrett explains exactly why that is and how it should change the way we view and approach our interactions. Dr. Barrett is among the top 1% most cited scientists in the world for her revolutionary research in psychology and neuroscience. She is a University Distinguished Professor of Psychology at Northeastern University, and she holds appointments at Harvard Medical School and Massachusetts General Hospital, where she serves as Chief Science Officer for the Center of Law, Brain and Behavior. In addition to the books 7 ½ Lessons About the Brain and How Emotions Are Made, Dr. Barrett has published over 260 peer reviewed scientific papers. Not only do we dive into the scientific research that disproves the way many of us have been led to view emotions, Dr. Barrett also does a phenomenal job of speaking to these concepts in a way that helps us apply it to our daily lives. Specifically, we address “The Great Man Theory” - why there is no one-size fits all approach to emotions and what they mean How understanding emotional constructs on a deeper level can make people more adept at navigating social situations The physiological and psychological processes of how we give meaning to our emotions Specific instances where knowing this information can directly influence life outcomes for you and those you impact daily Referenced Resources: Website: Lisafeldmanbarrett.com Book: How Emotions Are Made Book:  7 ½ Lessons About the Brain  TED Talk: You Aren't At the Mercy of Your Emotions Research Article: Knowing what you're feeling and knowing what to do about it   Resources & Links: Art of Coaching for coaching programs and resources: https://artofcoaching.com/mentoring My Latest Book (Link to upcoming or referenced publication): https://amzn.to/4rZknhs Connect with Brett Bartholomew: LinkedIn Twitter   Follow Us: Website: ArtofCoaching.com Instagram: @coach_brettb X: @coach_brettb

"Radiation therapy is often extremely well tolerated in colorectal cancer. Technology has really changed things. But location of the tumor can affect side effects, such as radiation dermatitis. If a patient has a low-lying tumor, if it's less than six centimeters from the anal verge, the patient is likely to have some skin reaction. It's good to be proactive if that's the case," ONS member Lorraine Drapek, DNP, FNP-BC, AOCNP®, nurse practitioner in the Department of Radiation Oncology at Massachusetts General Hospital in Boston, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about radiation side effects in colorectal cancer. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by June 5, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to the side effects of radiation to treat colorectal cancer. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Episode 374: Colorectal Cancer Treatment Considerations for Nurses Episode 301: Radiation Oncology: Side Effect and Care Coordination Best Practices Episode 194: Sex Is a Component of Patient-Centered Care ONS Voice articles: Frank Conversations Enhance Sexual and Reproductive Health Support During Cancer High-Fiber Diet Reduces Diarrhea in Colorectal Cancer Survivors Hyperbaric Oxygen Therapy Shows Promise for Certain Radiation Side Effects Increasing Incidence of Colorectal Cancer in Younger Adults Is a Call to Action for Oncology Nurses Oncology Drug Reference Sheet: 5-Fluorouracil Oncology Drug Reference Sheet: Oxaliplatin Oncology Nurses Are Key in Sexual Health Conversations With Minority Women Sexual Considerations for Patients With Cancer The Intersection of Pelvic Health and Oncology Optimizes Sexual Symptom Management ONS book: Manual for Radiation Oncology Nursing Practice and Education (fifth edition) ONS courses: ONS/ONCC® Radiation Therapy Certificate™ ONS ROCN™ Certification Review™ Clinical Journal of Oncology Nursing articles: Sexual Dysfunction: Common Side Effect Updated Interventions for Radiation-Induced Diarrhea: Putting Evidence Into Practice With the Oncology Nursing Society Physical Activity: A Systematic Review to Inform Nurse Recommendations During Treatment for Colorectal Cancer ONS Learning Libraries: Colorectal Cancer Radiation Advanced Practitioner Society for Hematology and Oncology American Society for Radiation Oncology American Society of Clinical Oncology Clinical Practice Guidelines Colontown Colorectal Cancer Alliance To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "In recent years, there has been more nonsurgical management of rectal cancer, especially in what we call the low-lying population. This is the population of patients who would likely end up with a permanent colostomy because their cancer is so low in terms of being close to or involving the anal verge. There is now a regimen where these patients can get their chemotherapy followed by their chemoradiation and then be monitored on close surveillance without surgery." TS 2:23 "Another assessment would be to assess what effects have they had from their chemotherapy that they're bringing with them. FOLFOX-based treatment is commonly used, and the platinum therapy oxaliplatin often causes peripheral neuropathy. What is the patient having? What are those symptoms like? Are they having peripheral neuropathy? If they are that is likely not going to get better or improve during their whole course of radiation. In fact, sometimes when oxaliplatin therapy stops, the peripheral neuropathy can get worse as patients are going through other treatments." TS 5:42 "If the patient has a low-lying tumor, if it's less than six centimeters from the anal verge, the patient is likely to have some skin reaction. It's good to be proactive if that's the case. And then proactively minimizing radiation dermatitis effects, such as keeping the area clean, good washing of the area, and prophylactically starting them on or having someone start them on steroid creams a couple of times a day to minimize that radiation dermatitis effect in the long run." TS 7:25 "I have a sexual health clinic for women with these effects. It's very important as nurses that if you can develop the comfort to ask patients about their sexual activity—it's hard, but it really needs to be done. And I will tell you that the healthcare providers are not doing it. They don't have time, and like us as nurses, we don't get this in school, and neither do they. The other providers don't get it in school either, but it's important. Patients are getting more and more worried about their sexual health. They're coming to us at a younger age, and this is really, really important to address." TS 15:35 "I would say that working with your advanced practice providers and education for advanced practice providers has definitely been focusing on [sexual health] more. Your PAs and your NPs—I think they're going to have the ears and the wherewithal to be able to be your allies and colleagues in this. By and large, it's my APP colleagues and nursing that I talk to the most about this. … Again, it's not an easy thing to bring forward, having dilators in place. But I will tell you in the department that I work in, it was me and couple of nurses who pushed this issue with the physicians for two years and finally got it put in place. It can be done. There's a lot more centers out there doing that." TS 21:51

What if the same brain states people spend years chasing through psychedelics could be accessed through meditation alone, and in as little as seven days? In this fascinating solo episode, Darin Olien explores groundbreaking new research from University of California San Diego, Harvard University, Massachusetts General Hospital, and University of Montreal suggesting that meditation may produce brain patterns remarkably similar to those observed during psychedelic experiences. From the suppression of the default mode network and increases in neural complexity to neuroplasticity, endogenous opioids, and measurable biological changes in the bloodstream, Darin unpacks the science behind one of the most powerful, and completely free tools available to human beings. He also walks listeners through a practical seven-day protocol combining focused-attention meditation, Vipassana, breathwork, walking meditation, and loving-kindness practices designed to help cultivate greater awareness, emotional resilience, cognitive flexibility, and inner peace. What You'll Learn The groundbreaking UC San Diego meditation study and its surprising findings Why meditation may create brain states similar to psilocybin What the default mode network is and how it shapes everyday thinking How meditation may reduce rumination, anxiety, and self-referential thought The concept of brain criticality and cognitive flexibility Why post-meditation blood samples stimulated neuronal growth How meditation influences neuroplasticity and whole-body biology The differences between Samatha and Vipassana meditation What advanced monks are teaching scientists about consciousness The limitations and caveats of current meditation research A practical seven-day meditation protocol anyone can begin Why meditation may be one of the most powerful health interventions available today Chapters 00:00:03 – Welcome to SuperLife 00:00:33 – Sponsor: Alkemis and the hidden toxicity of indoor air 00:00:57 – Conventional paints, petrochemicals, and endocrine disruptors 00:01:24 – Why VOCs and PFAS may be affecting your home environment 00:01:55 – Fire-resistant mineral paints and healthier living spaces 00:02:27 – Cradle to Cradle certification and sustainable design 00:03:23 – The meditation study Darin can't stop thinking about 00:03:33 – Scanning the brains and blood of meditators 00:03:44 – Brain activity resembling psilocybin experiences 00:04:09 – The promise of a seven-day meditation protocol 00:04:22 – Psychedelics, consciousness, and dissolving the sense of self 00:04:47 – Ancient practices and modern scientific validation 00:05:23 – Why meditation research is entering a renaissance 00:05:41 – Harvard, Massachusetts General Hospital, and advanced consciousness mapping 00:06:00 – University of Montreal's study of monks with 15,000+ hours of practice 00:06:16 – Why psychedelics and meditation are converging scientifically 00:06:37 – What listeners will learn in today's episode 00:06:54 – Breaking down the UC San Diego retreat study 00:07:18 – Thirty-three hours of meditation, breathwork, and group practice 00:07:42 – EEG scans, blood draws, and laboratory neuron testing 00:08:05 – Reduced activity in the default mode network 00:08:24 – The science of mental chatter and rumination 00:08:50 – Blood plasma stimulating new neuronal growth 00:09:02 – Neuroplasticity and new neural connections 00:09:29 – Increased cellular metabolism and endogenous opioids 00:10:13 – Samatha vs Vipassana meditation explained 00:10:42 – How different meditation styles reshape the brain 00:10:50 – Harvard's advanced meditation consciousness studies 00:11:18 – Mapping concentration states and consciousness cessation 00:11:46 – Ancient contemplative traditions meeting modern neuroscience 00:11:50 – Important limitations of the research 00:12:05 – Why advanced monks aren't average practitioners 00:12:20 – Correlation versus causation in psychedelic comparisons 00:12:48 – What may actually be happening inside the brain 00:13:03 – Understanding the default mode network 00:13:26 – Anxiety, depression, addiction, and overactive self-talk 00:13:53 – Why meditation and psilocybin share common neurological effects 00:14:10 – Beginner studies showing measurable brain changes 00:14:28 – Brain criticality and cognitive adaptability 00:14:48 – The most surprising finding: meditation changes the blood 00:15:05 – Meditation as a whole-body signaling event 00:15:18 – Better sleep, digestion, hormone balance, and recovery 00:15:39 – Neuroplasticity, immune function, metabolism, and pain regulation 00:15:56 – Why meditation may be the ultimate free medicine 00:16:10 – Introducing the seven-day meditation protocol 00:16:34 – Sponsor break: Alkemis Paint 00:19:02 – Building a research-backed at-home meditation practice 00:19:24 – Why consistency matters more than total hours 00:19:41 – Combining focused attention and open monitoring 00:19:53 – Days 1–3: Stabilizing attention 00:20:02 – Morning focused-attention meditation instructions 00:20:34 – Evening body scan practice 00:21:04 – Preparing the brain for deeper awareness 00:21:08 – Days 4–5: Opening awareness through Vipassana 00:21:31 – Letting thoughts, sensations, and sounds pass freely 00:21:39 – Evening box breathing for nervous system regulation 00:22:01 – Why days four and five often feel more challenging 00:22:11 – Days 6–7: Deepening and integrating the practice 00:22:27 – Walking meditation and embodied awareness 00:22:52 – Loving-kindness meditation and compassion training 00:23:02 – Vagal tone, heart rate regulation, and inflammation reduction 00:23:18 – Three rules that determine success 00:23:26 – Eliminating distractions and protecting attention 00:23:36 – Why you should never judge your meditation sessions 00:24:00 – Extending the practice beyond seven days 00:24:19 – Psychedelics, meditation, and the search for transformation 00:24:51 – What the medicine always teaches: sit with yourself 00:25:03 – The wellness industry's tendency to monetize stillness 00:25:20 – Why you don't need expensive tools to transform 00:25:36 – Meditation as radical self-reclamation 00:26:02 – Meeting yourself without distraction 00:26:17 – Final reflections and closing thoughts 00:26:29 – Outro and farewell Thank You to Our Sponsors Alkemis: Go to https://alkemispaint.com/ and use code DARIN10 for 10% off your order. Manna Vitality: Go to mannavitality.com/ and use code DARIN12 for 12% off your order. Join the SuperLife Patreon: This is where Darin now shares the deeper work: - weekly voice notes - ingredient trackers - wellness challenges - extended conversations - community accountability - sovereignty practices Join now for only $7.49/month at https://patreon.com/darinolien Find More from Darin Olien: Website: darinolien.com Instagram: @darinolien Book: Fatal Conveniences Platform & Products: superlife.com New Show: Roadmap to Happiness Key Takeaway "Perhaps one of the most profound discoveries emerging from modern neuroscience is that many of the states of awareness humans have sought through substances, rituals, and external interventions may already be available within us. Meditation is not simply a relaxation practice—it appears to be a biological, neurological, and consciousness-altering intervention capable of reshaping the brain, changing the body, and transforming how we experience reality. The question is not whether the door exists. The question is whether we are willing to sit still long enough to walk through it." Bibliography/Sources: Here is the fully formatted bibliography for the "Seven Days to a New Brain" episode. It is organized by category, formatted in strict APA Style (7th Edition), and includes a direct link for every single source : Primary Studies Brewer, J. A., Worhunsky, P. D., Gray, J. R., Tang, Y. Y., Weber, J., & Kober, H. (2011). Meditation experience is associated with differences in default mode network activity and connectivity. Proceedings of the National Academy of Sciences, 108(50), 20254–20259 . https://doi.org/10.1073/pnas.1112029108 Lieberman, J. M., Rahrig, H., Britton, W. B., et al. (2025). Toward a neuroscience of consciousness using advanced meditation. Neuroscience & Biobehavioral Reviews . https://meditation.mgh.harvard.edu/files/Lieberman_25_NeuroscienceAndBiobehavioralReviews.pdf Pascarella, A., Jerbi, K., et al. (2026). Meditation induces shifts in neural oscillations, brain complexity, and critical dynamics: Novel insights from MEG. Neuroscience of Consciousness . https://pubmed.ncbi.nlm.nih.gov/41287816/ Patel, H., et al. (2025). Intensive meditation retreat induces rapid changes in brain activity, blood-based biomarkers, and neurotrophic signaling. Communications Biology . https://today.ucsd.edu/story/meditation-retreat-rapidly-reprograms-body-and-mind Shinozuka, K., et al. (2025). Neuroelectrophysiological correlates of extended cessation of consciousness in advanced meditation [Preprint]. bioRxiv . https://meditation.mgh.harvard.edu/files/Shinozuka_25_bioRxiv.pdf Van Lutterveld, R., et al. (2025). An intensively sampled electroencephalography case study of advanced concentration absorption meditation (jhana) [Preprint]. SSRN . https://meditation.mgh.harvard.edu/files/VanLutterveld_25_SSRN.pdf Supporting Press Coverage & Explainers Harvard Gazette. (2026, January). Your brain on advanced meditation . https://news.harvard.edu/gazette/story/2026/01/your-brain-on-advanced-meditation/ Medical Xpress. (2026, February). Study of 12 monks finds meditation heightens brain activity, reshaping neural dynamics . https://medicalxpress.com/news/2026-02-monks-meditation-heightens-brain-reshaping.html PsyPost. (2026). Brain scans of Buddhist monks reveal how different meditation styles alter consciousness . https://www.psypost.org/brain-scans-of-buddhist-monks-reveal-how-different-meditation-styles-alter-consciousness/ ScienceDaily. (2026, April 6). Scientists say 7 days of meditation can rewire your brain . https://www.sciencedaily.com/releases/2026/04/260406192913.htm UC San Diego Today. (2026). Meditation retreat rapidly reprograms body and mind. UC San Diego News Center . https://today.ucsd.edu/story/meditation-retreat-rapidly-reprograms-body-and-mind Université de Montréal. (2026, January 5). Meditation doesn't rest the brain, it reshapes it. UdeMNouvelles . https://nouvelles.umontreal.ca/en/article/2026/01/05/meditation-doesn-t-rest-the-brain-it-reshapes-it  

In this episode, Kathryn Butler and Korrie Johnson offer advice and encouragement for parents hoping to engage their kids in reading. Kathryn Butler worked as a trauma surgeon at Massachusetts General Hospital before she left clinical practice to homeschool her children. She now writes regularly about faith, medicine, and the power of great stories. Korrie Johnson is a wife, a mom of three, and the founder of Good Book Mom, a ministry that reviews children's books from a biblical worldview. She has reviewed thousands of books for her website, and she collaborates with 10ofThose to offer families a biblical alternative to Scholastic Book Orders. They are also both co-authors of 'Stories Woven in Silver: Pointing Kids to the Gospel Through Children's Literature' from Crossway. ❖ Listen to “Unicorns, Allegory, and Stories That Give Us Hope" with Kathryn Butler:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Apple Podcasts | Spotify | YouTube If you enjoyed this episode, be sure to leave us a review, which helps us spread the word about the show.

"You shouldn't be spending more than five minutes in there at a time,” says Trisha Pasricha, MD, MPH. A graduate of Harvard College, Pasricha earned her medical degree from Vanderbilt University School of Medicine and a Master of Public Health from the Harvard T.H. Chan School of Public Health. Her training includes an internal medicine residency at The Johns Hopkins Hospital and gastroenterology and motility fellowships at Massachusetts General Hospital. Currently, Pasricha is an assistant professor of medicine at Harvard Medical School and director of the Institute for Gut-Brain Research at Beth Israel Deaconess Medical Center, an NIH-funded research laboratory at the forefront of gut-brain science. Her book, You've Been Pooping All Wrong, is out now.  00:00 - What actually makes a bowel movement healthy 07:55 - The Bristol Stool Chart explained 10:50 - The case for bidets 14:49 - What hemorrhoids actually are 17:44 - The smartphone-hemorrhoid study 20:33 - Fiber timing & psyllium husk 24:03 - The rise in early-onset colorectal cancer 27:43 - Microbiome testing 30:03 - The future of gut health 32:33 - Why we can't poop when traveling 35:40 - How much gas is actually normal 38:01 - Runners with the runs 41:10 - How to overhaul your gut in 30 days Referenced in the episode:  For more about Pasricha, visit her website: https://www.trishapasricha.com/  Buy Pasricha's book here: https://a.co/d/0gZZImBR  Smartphone usage on the toilet study: https://pmc.ncbi.nlm.nih.gov/articles/PMC12407481/ We hope you enjoy this episode, and feel free to watch the full video on YouTube! Whether it's an article or podcast, we want to know what we can do to help here at mindbodygreen. Let us know at: podcast@mindbodygreen.com. Learn more about your ad choices. Visit megaphone.fm/adchoices

Hosts: Jake Lancaster MD, Chief Medical Information Officer and Amanda Comer DNP, System Director, Advanced Practice ProvidersDr. Stephen Threlkeld, Baptist Memorial Health Care's medical director of infectious diseases, contributed to a case study published on Thursday, Jan. 8, 2026, in the prestigious New England Journal of Medicine titled “Case 1-2026: A 50-Year-Old Woman With Fever and Abdominal Pain.”The case study, published in Vol. 394, No. 2 of the journal, is part of a century-old series called “Case Records of the Massachusetts General Hospital.” It explores clinical cases that challenge physicians.CME Credit Info:Link to complete brief survey and claim CME credit: https://www.surveymonkey.com/r/C55LKSYCME credit is available for up to 3 years after the stated release dateContact CEOD@bmhcc.org if you have any questions about claiming credit.

Audible Bleeding editors Falen Demsas, an integrated vascular surgery resident at Massachusetts General Hospital, and Sasank Kalipatnapu (@ksasank), a fifth-year general surgery resident at UMass Chan Medical School, are joined by Megan Tracci (@MeganTracci), James Black (@JamesHBlackMD), and Lauren West-Livingston (LWestLivingston) for a discussion following the inaugural SVS Leadership and Advocacy Summit. In this episode, the group reflects on the importance of surgeon advocacy, highlights key takeaways from the Summit, and discusses how vascular surgeons throughout training and practice can engage in policy, leadership, and organized medicine at local and national levels. The conversation explores the evolving role of advocacy within the Society for Vascular Surgery, including the work of the SVS Advocacy Council and its collaboration across Government Relations, Coding, VA advocacy, and quality and policy initiatives. Dr. Tracci shares insights from her leadership roles within SVS advocacy efforts and her work as ACS Medical Director for Surgeon Engagement. Dr. Black discusses his longstanding advocacy work on behalf of patients and physicians, including numerous trips to Capitol Hill over the course of his career. Dr. West-Livingston reflects on her experience attending the recent Advocacy & Leadership Conference as a trainee and the importance of resident involvement in advocacy work. Show Guests Megan Tracci Leader within the SVS Advocacy Council, which includes Government Relations, Coding, VA advocacy, and quality and policy collaboration efforts. She also serves as the ACS Medical Director for Surgeon Engagement. James Black Chief of Vascular Surgery and Endovascular Therapy at Johns Hopkins University and longtime advocate who has made countless trips to Capitol Hill to advocate for patients and physicians. Lauren West-Livingston Integrated vascular surgery resident at Duke University and member of the SVS Government Relations Committee who attended the recent Advocacy & Leadership Conference. Notable Mentions The inaugural SVS Leadership and Advocacy Summit Advocacy efforts within the Society for Vascular Surgery, including Government Relations, Coding, VA advocacy, and quality and policy collaboration. Learn more here SVS Advocacy Council Opportunities for vascular surgeons to engage in advocacy throughout all stages of training and practice. Sign up for updates Follow us @audiblebleeding Learn more about us at Audible Bleeding and provide us with your feedback through our listener survey. Gore is a financial sponsor of this podcast, which has been independently developed by the presenters and does not constitute medical advice from Gore. Always consult the Instructions for Use (IFU) prior to using any medical device.

When a company proves it can see what others couldn't, the rules of drug development change overnight. Quantum BioPharma announced on May 18, 2026, that patient enrollment has reached the halfway mark in its collaborative imaging study with Massachusetts General Hospital, accompanied by encouraging preliminary results using a novel PET imaging technique capable of directly assessing demyelinated neurons with intact axons. The company's lead drug candidate, Lucid-MS, targets the underlying mechanism of multiple sclerosis—demyelination—rather than merely suppressing the immune system like most existing therapies. With an IND application submitted to the FDA on April 1, 2026, Quantum BioPharma is positioned at the intersection of breakthrough imaging science and first-in-class therapeutics.WHAT YOU NEED TO KNOWImaging Leap: PET scanning with [18F]3F4AP tracer provides up to 10x more accuracy than conventional MRI in measuring myelin damage and repair—potentially establishing a new FDA biomarker standard.Halfway Validated: First cohort successfully imaged at MGH showing robust signal in acute MS lesions; study completion expected within six months.First-in-Class: Lucid-MS targets PAD2 enzyme to prevent and reverse myelin breakdown—preclinical models demonstrated ability to help animals regain lost mobility.Commercial Scale: MS therapeutic market projected to exceed $38 billion by 2030, affecting 2.8 million patients worldwide with no current therapies addressing mobility restoration.STRATEGIC IMPLICATIONSThe MS treatment landscape is defined by what it cannot do. Virtually every approved therapy focuses on immune modulation—dampening the body's attack on its own myelin. But none address the underlying destruction happening to nerve fibers, and none restore lost mobility. Patients plateau on existing drugs, watching disease progression continue despite treatment. It's a multi-billion-dollar market built on managing symptoms, not reversing damage.Quantum BioPharma's approach disrupts that entire model. By targeting protein arginine deiminase 2 (PAD2)—the enzyme directly implicated in myelin degradation—Lucid-MS addresses neurodegeneration at its source. Phase 1 trials demonstrated a favorable safety profile. Preclinical models showed animals regaining the ability to walk. The oral formulation offers ease of administration versus injection-based competitors. And now, the MGH imaging partnership validates a tool that could measure myelin restoration in real time with unprecedented precision.CEO Zeeshan Saeed:“We've submitted the IND, we're at the halfway mark with MGH, and we're seeing preliminary imaging data that validates what we believed all along. This isn't about managing symptoms. It's about restoring what MS patients have lost. If this works—and we believe it will—we're talking about a fundamentally different standard of care.”INVESTOR TAKEAWAYQuantum BioPharma is executing on multiple fronts simultaneously: advancing a first-in-class therapeutic through FDA review, validating breakthrough imaging science with one of the world's premier hospitals, and preparing for Phase 2 initiation in a $38+ billion market with 2.8 million patients. The MGH study reaching its midpoint with encouraging preliminary results confirms the technical viability of precision myelin measurement. The IND submission positions Lucid-MS for near-term regulatory clarity. And the company's focus on demyelination—rather than immune suppression—addresses the core unmet need in MS: disease reversal, not just disease management. Quantum BioPharma offers investors exposure to a potentially transformative therapy at an inflection point in clinical and commercial validation.

In this episode, we talk with Dr. Nicholas Theodosakis, MD, PhD. Dr. Theodosakis is a physician scientist at Massachusetts General Hospital who completed his MD/PhD at Yale School of Medicine before going on to pursue a combined dermatology residency and research fellowship at the Harvard Combined Dermatology Residency Program. Today, Dr. Theodosakis tells us about his path to dermatology, what it looks like to have a career as a physician scientist and interesting recent findings from his lab that impact our understanding of the skin. Dr. Theodosakis also discusses opportunities for students to work in his research lab. We wrap up with general advice for students interested in research as well as building an application for the field of dermatology. We hope you enjoy!If you enjoyed this episode, please share it with other students interested in dermatology!Learn More:Educational links: Dr. Theodosakis research: https://pubmed.ncbi.nlm.nih.gov/41446198/Email: NTHEODOSAKIS@MGH.HARVARD.EDU---DIGA Instagram: @derminterestToday's Host, George: @georgepapadeas---For questions, comments, or future episode suggestions, please reach out to us via email at derminterestpod@gmail.com ---District Four by Kevin MacLeodLink: https://incompetech.filmmusic.io/song/3662-district-four**License: https://filmmusic.io/standard-license**---

Issued On Behalf of All Companies Mentioned Below. Quantum BioPharma Ltd. QNTM:NASDAQ | QNTM:CSE | 0K91:FSE Quantum BioPharma hit the halfway mark in its PET imaging study with Massachusetts General Hospital, with encouraging early data showing robust signal in acute MS lesions using the [18F]3F4AP tracer. The study validates direct imaging of demyelinated neurons — a key tool for advancing Lucid-MS, the company's lead candidate targeting PAD2 inhibition. Lucid-MS has demonstrated myelin repair in preclinical models, and a Phase 2 IND was submitted to the FDA in March 2026. Draganfly Inc. DPRO:NASDAQ | DPRO:CSE | 3U8:FSE Draganfly launched the Blitz™ payload platform as exclusive North American integrator for Blitz Technology, entering the EO/IR gimbal and drone payload market projected to exceed $12 billion annually by 2030. The Blitz family spans the Spectrum 300 (under 300g, dual EO/IR) to the Spectrum 1600LR (long-range ISR with laser rangefinding), engineered for defense, border security, and public safety. The platform debuts at SOF Week 2026 in Tampa, Florida. Power Metallic Mines Inc. PNPN:TSXV | PNPNF:OTC Markets | IVV1:Frankfurt Stock Exchange Power Metallic entered a 50/50 joint venture framework with Amaar United Mining Company to pursue mining licenses in Saudi Arabia. Amaar Mining will contribute US$7.5 million and Power Metallic US$2.5 million of the initial US$10 million work-program, with equal funding thereafter. Power Metallic acts as technical lead, leveraging its Jabal Baudan license covering 200+ square kilometers in the copper, gold, and zinc-prospective Jabal Sayid Mineralized Belt.Nextech3D.ai NTAR:CSE | NEXCF:OTCQB | 1SS:FSE Nextech3D.ai announced it will serve as lead sponsor and speaker at an EMRG Media event in New York City (October 27-29, 2026), showcasing its Krafty Labs Experience Marketplace alongside its Eventdex registration platform. The integrated AI Event Operating System consolidates engagement, lead capture, and monetization into one unified platform — enabling sponsors measurable ROI through interactive, data-driven experiences. Eventdex will manage full event registration, badge pre-printing, and lead retrieval at the three-day trade show. HPQ Silicon Inc. HPQ:TSXV | HPQFF:OTCQB | O08:FSE HPQ Silicon announced that its French technology partner Novacium SAS signed a Letter of Intent with GH Technologies Co., Ltd. at the 18th China International Battery Fair (May 15, 2026), covering a 36-month framework for GEN4 lithium-ion cells in 18650 and 21700 formats across Asia-Pacific. GEN4 cells feature reported capacity exceeding 6,600 mAh and energy density of 319.9 Wh/kg. HPQ holds a 36.8% equity stake in Novacium and exclusive North American rights under the ENDURA+ trademark. Asia-Pacific accounts for over 57% of global cylindrical Li-ion demand. Stay ahead of the market — follow AGORACOM for more breaking small-cap news and insights.

Welcome to the Oncology Brothers podcast! In this episode, we dived into the complexities of chronic myeloid leukemia (CML) through two challenging case studies. Joined by CML experts Dr. Fadi Haddad from MD Anderson Cancer Center and Dr. Gaby Hobbs from Massachusetts General Hospital,  Listen us on: Spotify: https://open.spotify.com/show/31BXhY9FM4gPWG10WgE11o Apple Podcast: https://podcasts.apple.com/us/podcast/oncology-brothers-practice-changing-cancer-discussions/id1653340966 Follow us on social media: X/Twitter: https://twitter.com/oncbrothers ⁠Instagram: https://www.instagram.com/oncbrothers Website: https://oncbrothers.com/ we talked about: The initial workup for diagnosing CML, including the importance of CBC, bone marrow biopsy, and BCR-ABL testing. How to select the most optimal frontline treatment option amongst many available, considering factors like age, comorbidities, and the goal of treatment-free remission (TFR). The role of first-generation TKI, but also how newer TKIs assist in achieving deeper molecular remissions. Strategies for managing treatment breaks and monitoring patients in remission. The role of ponatinib as a pan-BCR:ABL1 inhibitor effective against all known resistance mutations, including T315I, and the optimized response-based dosing strategy to balance efficacy with safety. Tune in for valuable insights on treatment strategies, patient management, and the latest advancements in CML care. Don't forget to like, subscribe, and share your challenging case scenarios for future discussions! #ChronicMyeloidLeukemia, #CML, #TreatmentFreeRemission, #OncologyBrothers

In this episode of The Visible Voices Podcast, I speak with Dr. Michelle Finkel, emergency medicine physician turned entrepreneur and founder of Insider Medical Admissions — a specialized consulting business helping applicants navigate medical school, residency, fellowship, post-bac, and dental school admissions. Drawing on her experience as faculty at Massachusetts General Hospital and assistant residency director, Michelle shares her high-touch, human-centered approach to helping applicants find their voice, avoid the humility trap, and write with persuasion and originality. We also talk about what it means to embrace a nonlinear career — and why that shift in perspective can reduce stress and open unexpected doors. Find Michelle at insidermedicaladmissions.com ▶ Subscribe on YouTube @resaelewissmd — new Visible Voices episodes on Wednesdays.

In this episode of Bowel Sounds, hosts Dr. Temara Hajjat and Dr. Peter Lu talk to Dr. Maureen Leonard, a pediatric gastroenterologist and Associate Professor at Massachusetts General Hospital. Dr. Leonard discusses the latest research on early life factors that can increase celiac disease risk for susceptible children, including potentially modifiable risk factors. Dr. Leonard's disclosures include:  Consultant for Takeda, Chugai, Anokion, Sonoma, and Interlude Biopharma and research support from Takeda, Pfizer, Regeneron, Moderna, and Mead Johnson Nutrition.Learning objectivesUnderstand early life determinants for celiac diseaseUnderstand environmental influences on developing celiac diseaseSend us Fan MailSupport the showThis episode may be eligible for CME credit!  Once you have listened to the episode, click this link to claim your credit.  Credit is available to NASPGHAN members (if you are not a member, you should probably sign up).  And thank you to the NASPGHAN Professional Education Committee for their review!As always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.Check out our merch website!Follow us on Bluesky, Twitter, Facebook and Instagram for all the latest news and upcoming episodes.Click here to support the show.

President Trump is in China with a delegation drawing scrutiny across Washington: family members, billionaire tech allies and business figures appear front and center, while longtime China experts and senior State Department voices are far less visible. Is Trump on the verge of a corrupt deal for himself and his family that won't serve U.S. or historic interests? Is he prioritizing dealmaking and optics over diplomacy and strategy? Where are experienced American diplomatic voices at this pivotal moment? Mo Kelly is in for Mark Thompson and will discuss this and more. We welcome former federal prosecutor and now defense attorney David Katz to talk about the impending Trump deal with the IRS, redistricting battles headed to court and criticism of the Supreme Court. Then, we pivot to marijuana. Mark welcomes Dr. Peter Grinspoon. He is a primary care physician and a board-certified addiction specialist at Massachusetts General Hospital. Dr. Grinspoon's upcoming book is titled “Aging Well with Cannabis: Feel Better, Sleep Better and Live Better with Marijuana and CBD.” It's a culmination of his hard work to help ‘canna-curious' seniors, family members, and caregivers by providing practical instructions, real-life case studies, and a balanced view of the benefits and risks of cannabis and CBS.

Dr. Peter Grinspoon—author of the new book Aging Well with Cannabis: Feel Better, Sleep Better, and Live Better with Marijuana and CBD—explains that senior citizens are the fastest growing demo of cannabis consumers. But they often need help accessing information and safely ingesting the plant. Dr. Grinspoon is a primary care physician and educator at Massachusetts General Hospital, an Instructor in Medicine at Harvard Medical School, and serves as a board member of the advocacy group Doctors For Cannabis Regulation, which works on legalizing cannabis with an eye toward social justice issues.  PATREON Please ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠support Great Moments in Weed HIstory on Patreon⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. Supporters get exclusive access to video versions of this podcast and private seshes, plus cool rewards like a signed book. And it truly helps us make the best show possible. EPISODE ARCHIVE Visit our podcast feed for 150+ episodes of Great Moments in Weed History, and subscribe now to get a new weekly podcast every Weednesday.

In this week's podcast episode, Emma shares the story of her son Grady's unexpected NICU journey after experiencing a rare neonatal stroke at birth. What began as a healthy, full-term pregnancy quickly turned into a series of medical emergencies, including respiratory distress, seizures, an emergency transfer to Massachusetts General Hospital, and the discovery of multiple blood clots in Grady's brain.Emma vulnerably reflects on the fear, uncertainty, and trauma of navigating the NICU as a first-time mom while also sharing the hope, resilience, and compassion that carried their family through. As May is Stroke Awareness Month, we are especially honored to share Grady's story and help raise awareness about neonatal stroke and its lasting impact on families.As you listen to Emma's story, we hope that NICU moms navigating unexpected diagnoses or medical trauma feel seen, supported, and reminded that they are never alone!To get connected with DNM:Website | Private Facebook Group | InstagramSupport the show

We can measure more about our health than ever before. Wearables track everything from heart rhythms to glucose trends, and AI can now identify patterns clinicians might miss. But more data does not automatically mean better health outcomes.In this episode, cardiologist and digital health expert Dr. Ami Bhatt joins Mike Haney to explore why medicine still struggles with prevention, how continuous health data can help patients take more agency, and where AI may actually improve care—not by replacing doctors, but by helping clinicians navigate the right information at the right time.They discuss the promise and pitfalls of wearables, the challenge of turning constant streams of health information into useful action, and why the future of medicine may depend on what Dr. Bhatt calls “collaborative intelligence”: humans and AI working together to make better decisions earlier.About the guest: Dr. Ami Bhatt is the chief innovation officer (CIO) at the American College of Cardiology and the Chair of the FDA Digital Health Advisory Committee. She received her undergraduate degree at Harvard University and her Doctor of Medicine at Yale University School of Medicine, and was the Director of Outpatient Cardiology, TeleCardiology, and Adult Congenital Heart Disease at the Massachusetts General Hospital.Sign Up to Get Your Free Ultimate Guide to Glucose: ⁠⁠⁠⁠⁠⁠⁠https://levels.link/wnl⁠⁠⁠⁠⁠⁠

On this week's episode of the Brain & Life Podcast, co-host Dr. Katy Peters talks with Samantha Lee Schmall, author of Beyond the Shunt, about her personal journey with hydrocephalus. Samantha reflects on growing up with the condition, what inspired her to share her story, and how she's found connection and support within the hydrocephalus community. Dr. Peters is also joined by Dr. Kristopher Kahle, Director of Pediatric Neurosurgery at Massachusetts General Hospital and the Harvard Center for Hydrocephalus and Neurodevelopmental Disorders, who explains what causes hydrocephalus, common symptoms, and current treatment options, including shunts.   Additional Resources Samantha Lee Schmall- Beyond the Shunt Understanding Hydrocephalus: Symptoms, Diagnosis, and Treatment Options Average Joe- Speak Up   Related Episodes of Brain & Life Podcast Author Tanita Allen on Existing with Huntington's Disease A Walk in the "Parkinson's" with Author Annmarie O'Connor Movement and Healing with Adventure Athlete, Author, and Activist Rebecca Rusch   We want to hear from you! Have a question or want to hear a topic featured on the Brain & Life Podcast? ·       Record a voicemail at 612-928-6206 ·       Email us at BLpodcast@brainandlife.org   Social Media Guests: Samantha Lee Schmall @beyondtheshunt; Dr. Kahle @mgbneurosurgery Hosts: Dr. Daniel Correa @neurodrcorrea; Dr. Katy Peters @KatyPetersMDPhD

We love to hear from our listeners. Send us a message.In episode 128, Host Erin Harris talks to Tatyana Matveeva, Ph.D., Director of cGMP Operations at George  A. "Doc"  Lopez, MD Laboratory for Regenerative Cell Therapy, Harvard Medical School and Massachusetts General Hospital, about leading cGMP operations within an integrated ecosystem, where manufacturing, research, and neurosurgery coexist. Dr. Matveeva highlights key operational challenges in scaling autologous therapies, particularly around technology transfer, process reproducibility, and regulatory readiness, emphasizing the need for early collaboration between research and GMP teams. Their conversation also explores rigorous approaches to chain of identity and custody, the importance of extensive simulation runs to ensure robustness, the unique sensitivities of manufacturing cells for neurological applications, and more.Subscribe to the podcast!Apple  |  Spotify |  YouTubeVisit my website: Cell & GeneConnect with me on LinkedIn

What do tattoos, trafficking survivors, and longevity medicine have in common? More than you'd think. In this episode of Science is Skin, board-certified dermatologist Dr. Ted Lain sits down with Dr. Shadi Kourosh — Harvard Medical School professor, public health physician, and director of dermatology at Nantucket Cottage Hospital — for a conversation that spans medicine, advocacy, and cutting-edge science. Dr. Kourosh shares how her work with underserved communities at Massachusetts General Hospital led her to the frontlines of the fight against human trafficking. She breaks down the "Three I's" — infections, injuries, and imagery — the clinical signs dermatologists and healthcare providers should recognize when a patient may be a trafficking victim. She also discusses trauma-informed care, how to create a safe environment for disclosure, and the STEER app (Skin Signs of Trafficking Education Advocacy and Resources), a free tool designed to connect providers and survivors with local resources. In the second half, Dr. Kourosh pivots to longevity medicine — one of dermatology's fastest-growing frontiers — and explains why separating skin science from snake oil has never been more important for patient protection and consumer health. In this episode: How dermatologists can identify skin signs of human trafficking The Three I's framework: infections, injuries, and imagery in trafficking tattoos Trauma-informed care and the "warm handoff" approach for at-risk patients The STEER app and AAD Human Trafficking Toolkit — free resources for providers Laser tattoo removal as a pathway to safety and reintegration for survivors The new science of skin longevity and preventive dermatology Fact vs. fiction in the longevity medicine space Resources mentioned: STEER App (Skin Signs of Trafficking, Education, Advocacy & Resources) AAD Human Trafficking Toolkit: aad.org American Society for Laser Medicine and Surgery (ASLMS) Polaris Project National Human Trafficking Hotline To watch this and other episodes, be sure to check out our YouTube page DISCLAIMER: This podcast is not intended to provide diagnosis, treatment, or medical advice. Content provided in this podcast is for educational purposes only. Please consult with a physician regarding any health-related diagnosis or treatment.See omnystudio.com/listener for privacy information.

Season 10, Episode 10: Clearing the Fog: A Clinical Look at Chemo Brain with Jorg Dietrich, MD, PhD Cognitive changes during cancer treatment, often called “chemo brain,” can significantly impact a patient's quality of life. In this episode, Jorg Dietrich, MD, PhD, Clinical Director of the Cancer & Neurotoxicity Clinic at Massachusetts General Hospital and Associate Professor of Neurology at Harvard Medical School, shares his expertise on the neurologic effects of cancer therapies. Dr. Dietrich discusses the biology behind treatment-related cognitive changes, including the impact of chemotherapy, radiation, and immunotherapy on the brain's cellular environment. He provides insight into how these symptoms present in clinical practice and how they can vary across patients. The conversation also focuses on practical strategies for the multidisciplinary oncology team. From early recognition and patient education to supportive care approaches, this episode highlights how pharmacists, providers, and the broader care team can work together to address cognitive side effects and improve patient outcomes. Dr. Dietrich brings a unique perspective through his leadership in cancer neuroscience and brain repair research, with over 200 publications advancing the understanding of neurotoxicity and recovery in cancer care. This episode offers valuable insight for oncology professionals looking to better support patients experiencing cognitive changes throughout their treatment journey.

What does recovery look like — and how do we measure it? In this episode, we're joined by Dr. John Kelly, one of the world's leading addiction researchers and founder of the Recovery Research Institute at Harvard Medical School, for a deep dive into the science behind what makes recovery possible, sustainable, and real. Dr. Kelly breaks down the difference between remission and recovery, shares what decades of research tells us about who gets better (spoiler: most people do) and unpacks the active ingredients that help people build lives they love. We also get into the language we use around addiction, why it matters more than you think, and what the latest science says about stigma, stages of change, and recovery capital. Whether you are in recovery, supporting someone who is, or working in the field — this episode is packed with hope, science, and practical insight. ━━━━━━━━━━━━━━━━━━━━━━━━━━━━

In this bonus episode recorded live at the Collegis Education DisruptED summit in Phoenix, we spoke with Marc Austin and Reamer Bushardt to explore how partnerships between higher education institutions and employers can drive more relevant, workforce-aligned learning experiences. Through examples from healthcare and university initiatives, the conversation highlights how co-designed programs, continuous feedback loops, and shared goals can better prepare students for real-world careers.  The discussion emphasizes that successful partnerships require trust, aligned values, and ongoing collaboration—not just transactional agreements. Ultimately, when done well, these partnerships create meaningful pathways for students, improve career outcomes, and strengthen the connection between education and the evolving needs of the workforce. Guest Names:  Dr. Marc Austin, Vice Provost & Managing Director, Montclair Unbound Reamer Bushardt, Provost & VP for Academic Affairs, MGH Institute of Health Professions Guest Socials:Marc's LinkedIn Reamer's LinkedIn Guest Bios: Dr. Marc Austin serves as the Vice Provost and Managing Director for Montclair Unbound, Montclair State University's unit dedicated to extending the reach of the university through online and blended forms of education. Previously, he was the Associate Provost and Dean of Augusta University Online.  Dr. Austin has spent the past two decades launching new, innovative approaches to online, executive and adult learning programs. Dr. Austin has also been a featured speaker for WCET, The Chronicle of Higher Education, ASU/GSV and others. He holds a PhD from Columbia University, a MSc from the London School of Economics and a BA from the University of Pennsylvania. Reamer L. Bushardt, PharmD, PA-C, DFAAPA serves as Professor, Provost and Vice President for Academic Affairs at the MGH Institute of Health Professions, which was founded by the Massachusetts General Hospital and is the only degree granting member of Mass General Brigham. As Provost, he is the Institute's chief academic officer with responsibility for all academic programs, research programs, faculty, and students. Dr. Bushardt is a seasoned educator, researcher, clinician, and administrator with experience in rural, community-based practice and faculty service within four academic health centers. He is licensed as a PA and pharmacist, specializing in the care of older adults and management of inappropriate polypharmacy and drug injury. As a PA, he has spent more than twenty-three years in primary care practice. - - - -Connect With Our Host:Dustin Ramsdellhttps://www.linkedin.com/in/dustinramsdell/About The Enrollify Podcast Network:The Higher Ed Geek is a part of the Enrollify Podcast Network. If you like this podcast, chances are you'll like other Enrollify shows too!Enrollify is made possible by Element451 — The AI Workforce Platform for Higher Ed. Learn more at element451.com. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Every true crime story has a before. In the Lindsay Clancy case, the before is everything.Lindsay Clancy was a labor and delivery nurse at Massachusetts General Hospital — a woman who worked the room where lives begin and who dedicated her professional life to supporting mothers through their most vulnerable moments. When she became a mother herself, those professional instincts kicked in immediately. She recognized her own symptoms. She sought help almost immediately after each birth. She described exactly what she was experiencing using clinical language, because she had it.She was prescribed medication. It allegedly made things worse. She went back. More medications were added. She went back again. She admitted herself to hospital programs. She kept journals. Her husband was sounding alarms to friends. Her family drove in from out of state to help with the children.And according to a civil malpractice lawsuit she filed in January 2026, through all of it — across more than two years and three pregnancies — no one ever correctly identified the underlying condition that may have been driving everything.Part 2 of our five-part Lindsay Clancy series covers the years before January 24th, 2023. The woman, the mother, the patient, and the pattern of deterioration that her family watched happen while the system allegedly missed it entirely.Join Our SubStack For AD-FREE ADVANCE EPISODES & EXTRAS!: https://hiddenkillers.substack.com/Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/channel/UC8-vxmbhTxxG10sO1izODJg?sub_confirmation=1Instagram https://www.instagram.com/hiddenkillerspod/Facebook https://www.facebook.com/hiddenkillerspod/Tik-Tok https://www.tiktok.com/@hiddenkillerspodX Twitter https://x.com/TrueCrimePodThis publication contains commentary and opinion based on publicly available information. All individuals are presumed innocent until proven guilty in a court of law. Nothing published here should be taken as a statement of fact, health or legal advice.#LindsayClancy #TrueCrimeToday #TrueCrime #PostpartumPsychosis #MaternalMentalHealth #TrueCrimePodcast #MentalHealthAwareness #DuxburyMurder #HiddenKillers #WomenTrueCrime

Patrick Clancy came home with dinner on January 24th, 2023. His wife was injured in the backyard. His three children were in the basement. Cora was five. Dawson was three. Callan was eight months old. Within 72 hours, all three were gone.Lindsay Clancy — a devoted mother and labor and delivery nurse at Massachusetts General Hospital — allegedly strangled all three children with exercise bands before attempting to take her own life by jumping from a second-story window. She survived. She is now paralyzed from the chest down, held at Tewksbury State Hospital, awaiting a trial currently scheduled for July 2026.She has pleaded not guilty. Prosecutors allege premeditation — that she calculated Patrick's absence, sent him on a deliberate errand, and created the window intentionally. Her defense maintains she was in active psychosis at the time, hearing a commanding voice she could not resist, the result of a serious illness the medical system allegedly failed to diagnose or treat.In the days after the deaths, Patrick released a public statement of forgiveness that divided the country. The debate it sparked has never stopped.Part 1 of our five-part deep-dive into the Lindsay Clancy case, presented in partnership with Hidden Killers, establishes the foundation: who was lost, who Lindsay was, and what it looks like when two opposing accounts of the same devastating night collide for the first time.Join Our SubStack For AD-FREE ADVANCE EPISODES & EXTRAS!: https://hiddenkillers.substack.com/Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/channel/UC8-vxmbhTxxG10sO1izODJg?sub_confirmation=1Instagram https://www.instagram.com/hiddenkillerspod/Facebook https://www.facebook.com/hiddenkillerspod/Tik-Tok https://www.tiktok.com/@hiddenkillerspodX Twitter https://x.com/TrueCrimePodThis publication contains commentary and opinion based on publicly available information. All individuals are presumed innocent until proven guilty in a court of law. Nothing published here should be taken as a statement of fact, health or legal advice.#LindsayClancy #TrueCrimeToday #TrueCrime #PostpartumPsychosis #DuxburyMassachusetts #PatrickClancy #MurderCase #MaternalMentalHealth #TrueCrimePodcast #CriminalJustice

Today we're talking about motivation—what it is, what it isn't, and why so many of our neurodivergent kids get mislabeled as “unmotivated” when the real story is far more nuanced. My guest is Dr. Ellen Braaten, an expert on motivation and the author of several books including Bright Kids Who Couldn't Care Less, and her newest release, The Motivation Mindset Workbook: Helping Teens and Tweens Discover What They Love to Do. Ellen shares why motivation is not a fixed trait, how identity shapes whether kids lean in or shut down, and what often gets in the way for learners with ADHD and other differences. We talk about how parents can shift from pushing performance to supporting purpose, and how giving kids the space to discover what genuinely interests them can be transformative for confidence, engagement, and long-term growth. About Dr. Ellen Braaten  Dr. Ellen Braaten is the founding director of the Learning and Emotional Assessment Program (LEAP) at Massachusetts General Hospital and an associate professor at Harvard Medical School. She has published numerous scientific papers on topics related to ADHD, learning disorders, child psychopathology, processing speed, and intelligence, as well as many books for parents and professionals, including the bestsellers Bright Kids Who Can't Keep Up, and Bright Kids Who Couldn't Care Less: How to Rekindle Your Child's Motivation. Most recently, she coauthored The Motivation Mindset Workbook: Helping Teens and Tweens Discover What They Love to Do.Dr. Braaten has a strong interest in educating the public on topics related to child mental health, maintains an active speaking schedule, and contributes regularly to local and national news outlets. Things you'll learn from this episode  How motivation is a dynamic skill that ebbs and flows based on environment and context, not a fixed trait Why helping teens and tweens identify their strengths and values lays the foundation for authentic motivation How responsibility and meaningful real-world experiences spark engagement and ownership Why identity development plays a central role in sustaining long-term motivation How practical, strengths-based activities can reignite momentum when kids feel stuck Resources mentioned  Dr. Ellen Braaten's website The Motivation Mindset Workbook: Helping Teens and Tweens Discover What They Love to Do by Dr. Ellen Braaten & Dr. Hillary Bush Bright Kids Who Couldn't Care Less: How to Rekindle Your Child's Motivation by Dr. Ellen Braaten Bright Kids Who Can't Keep Up: Help Your Child Overcome Slow Processing Speed and Keep Up in a Fast-Paced World by Dr. Ellen Braaten How to Rekindle Your Child's Motivation, with Dr. Ellen Braaten (Tilt Parenting Podcast) Exploring Slow Processing Speed with Dr. Ellen Braaten (Tilt Parenting Podcast) Traits of Flow According to Mihaly Csikszentmihalyi The Clay Center for Young Healthy Minds Dr. Martin Seligman / Positive Psychology Learn more about your ad choices. Visit podcastchoices.com/adchoices

Identification of pancreatic cystic lesions has become increasingly common due to improved resolution and increased utilization of cross-sectional imaging. However, there are many types of pancreatic cysts, each with varying degrees of malignant potential. In this episode from the HPB team at Behind the Knife, listen in as we discuss the clinical presentation, diagnostic work-up, and management strategies for various pancreatic cysts: Pseudocysts, Serous Cystadenomas, Mucinous Cystic Neoplasms, and IPMNs, amongst others. HostsAnish J. Jain MD (@anishjayjain) is a current PGY4 General Surgery resident at Stanford University and a former T32 Research Fellow at the University of Texas MD Anderson Cancer Center.Jon M. Harrison MD is a Hepatobiliary & Pancreatic (HPB) surgeon at the Massachusetts General Hospital in Boston, MA and a former HPB Surgery fellow at Stanford University. Learning Objectives·      Develop an understanding of the clinical presentation, diagnostic work-up, and treatment of benign pancreatic cysts·      Develop an understanding of the clinical presentation, diagnostic work-up, and treatment of pre-malignant pancreatic cysts·      Develop an understanding of when surveillance is appropriate for management of pancreatic cysts, and the criteria involved in making that determination·      Develop an understanding of the prognostic utility of PancSeq for IPMNsReferences: Paniccia A, Polanco PM, Boone BA, et al. Prospective, Multi-Institutional, Real-Time Next-Generation Sequencing of Pancreatic Cyst Fluid Reveals Diverse Genomic Alterations That Improve the Clinical Management of Pancreatic Cysts. Gastroenterology. 2023 Jan;164(1):117-133.e7.PubMed Link: https://pubmed.ncbi.nlm.nih.gov/36209796/ Ohtsuka T, Fernandez-Del Castillo C, Furukawa T, et al. International evidence-based Kyoto guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas. Pancreatology. 2024 Mar;24(2):255-270.PubMed Link: https://pubmed.ncbi.nlm.nih.gov/38182527/ Zelga P, Hernandez-Barco YG, Qadan M, et al. Number of Worrisome Features and Risk of Malignancy in Intraductal Papillary Mucinous Neoplasm. J Am Coll Surg. 2022 Jun 1;234(6):1021-1030.PubMed Link: https://pubmed.ncbi.nlm.nih.gov/35703792/ Ciprani D, Weniger M, Qadan M, et al. Risk of malignancy in small pancreatic cysts decreases over time. Pancreatology. 2020 Sep;20(6):1213-1217.PubMed Link: https://pubmed.ncbi.nlm.nih.gov/32819844/ ***Fellowship Application Link: https://forms.gle/QSUrR2GWHDZ1MmWC6Sponsor Disclaimer: Visit goremedical.com/btkpod to learn more about GORE® SYNECOR Biomaterial, including supporting references and disclaimers for the presented content.Refer to Instructions for Use at eifu.goremedical.com for a complete description of all applicable indications, warnings, precautions and contraindications for the markets where this product is available. Rx only Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listenBehind the Knife Premium:General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-reviewTrauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlasDominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkshipDominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotationVascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-reviewColorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-reviewSurgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-reviewCardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-reviewDownload our App:Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

Electronic Medical Records have transformed the way we practice health care, making patient data readily accessible to health care providers, facilitating collaboration within and across large medical teams, increasing transparency, and drastically improving the legibility of patient charts and prescriptions. But despite these benefits, many physicians cite the electronic medical record as a primary driver of burnout, pointing to the overwhelming volume of documentation it requires. In this episode, we explore how the launch of EMRs within the context of America's predominantly fee-for-service health care system led to the technology falling short of its promise — and how transitioning to value-based care models might redeem the technology, revitalize physicians, and recenter public health. Our guest on this episode is Farzad Mostashari, MD. After completing a degree in public health at Harvard, medical school at Yale, and residency at Massachusetts General Hospital, Dr. Mostashari spent over a decade working in public health: first for the CDC's Epidemic Intelligence Service and then for the New York City Department of Health. From 2009 to 2011, he served as the National Coordinator for Health IT at the Department of Health and Human Services where he helped oversee the nationwide transition from paper to electronic medical records. In 2014, he founded Aledade, a company that helps primary care physicians form value-based care networks in the US.  Over the course of our conversation, Dr. Mostashari shares how his childhood in Iran pushed him towards public health, how his experience watching his father being cared for in the hospital drove him towards medicine, and how he has spent his career in the liminal space between public health and medicine. We discuss the rollout of EMRs, and how fee-for-service payment models led to EMRs being optimized for documentation rather than patient care. We explore how value-based care not only solves the problem of over-documentation, but also better aligns the goals of patients, physicians, and even insurance companies. Dr. Mostashari maps out the progress we have made toward this kind of model and the hurdles we have to clear before we have a system that incentivizes preventing stroke as much as treating stroke. In this episode, you'll hear about: 3:35 - How Dr. Mostashari became drawn to the intersection between the intimate work of doctoring and the wide lens work of public health. 12:12 - Dr. Mostashari's experiences modernizing health IT systems and learning to optimize for the number of lives saved rather than the number of technological solutions implemented.16:05 - Dr. Mostashari's assessment of the rollout of the electronic medical record in the US.25:09 - How Aledade frees primary care physicians to prioritize patient outcomes and reduces the burden of EMR documentation.38:57 - What the US can learn from international health care systems. 41:00 - Challenges in transitioning to outcome-based models of primary care.50:30 - How Dr. Mostashari's medical training has shaped his career in public health. If you enjoyed this episode, please subscribe, rate, and review our show, available for free on Spotify, Apple Podcasts, or wherever you get your podcasts. If you know of a doctor, patient, or anyone working in health care who would love to explore meaning in medicine with us on the show, feel free to leave a suggestion in the comments or send an email to info@thedoctorsart.com.Copyright The Doctor's Art Podcast 2026